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ARF GTPases and their GEFs and GAPs: 
concepts and challenges
ABSTRACT Detailed structural, biochemical, cell biological, and genetic studies of any gene/
protein are required to develop models of its actions in cells. Studying a protein family in the 
aggregate yields additional information, as one can include analyses of their coevolution, 
acquisition or loss of functionalities, structural pliability, and the emergence of shared or 
variations in molecular mechanisms. An even richer understanding of cell biology can be 
achieved through evaluating functionally linked protein families. In this review, we summarize 
current knowledge of three protein families: the ARF GTPases, the guanine nucleotide ex-
change factors (ARF GEFs) that activate them, and the GTPase-activating proteins (ARF GAPs) 
that have the ability to both propagate and terminate signaling. However, despite decades 
of scrutiny, our understanding of how these essential proteins function in cells remains frag-
mentary. We believe that the inherent complexity of ARF signaling and its regulation by GEFs 
and GAPs will require the concerted effort of many laboratories working together, ideally 
within a consortium to optimally pool information and resources. The collaborative study of 
these three functionally connected families (≥70 mammalian genes) will yield transformative 
insights into regulation of cell signaling.
INTRODUCTION
Members of the family of regulatory GTPases that include ARFs, 
ARF-like (ARLs), and SARs have emerged as key regulators of cellu-
lar signaling involved in almost all aspects of cell biology (Tables 1–
3, Figure 1, and Supplemental Tables I–III) (D’Souza-Schorey and 
Chavrier, 2006; Donaldson and Jackson, 2011; Jackson and Bouvet, 
2014). Their importance is underscored by findings showing that 
complete or conditional deletions or mutations result in embryonic 
lethality or organ-specific defects, with links to a variety of diseases 
(Table 4) (Seixas et al., 2013; Zhang et al., 2013). ARF family GTPases 
control key cellular processes, including bidirectional membrane 
trafficking (secretion and endocytosis), ciliogenesis, lipid metabo-
lism, energy use, motility, division, apoptosis, and transcriptional 
regulation. Like all regulatory GTPases, ARF family GTPases operate 
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GTPase Localization Function(s) Interactors
1 Arf1 Cytosol, Golgi Recruitment of coat complexes, 
activation of PLD, PI kinases
COP-I, GGAs, MINTs, Cholera toxin, 
Arfaptin, MKLP1, ARF GEFs, ARF GAPs
2 Arf3 Cytosol, Golgi Recruitment of coat complexes, 
activation of PLD, PI kinases
COP-I, GGAs, MINTs, Cholera toxin, 
Arfaptin, MKLP1, ARF GEFs, ARF GAPs
3 Arf4 Cytosol, Golgi, endosomes COP-I, GGAs, MINTs, Cholera toxin, 
Arfaptin, MKLP1, ARF GEFs, ARF GAPs
4 Arf5 Cytosol, Golgi, endosomes Recruitment of coat complexes, 
activation of PLD, PI kinases
COP-I, GGAs, MINTs, Cholera toxin, 
Arfaptin, MKLP1, ARF GEFs, ARF GAPs
5 Arf6 PM, endosomes, RE, cortical 
actin
Cortical actin rearrangement, 
endocytosis, PLD activation
β-arrestin, POR1, PLD, Cytohesins, 
MKLP1, FilGAP
6 Arl1 Golgi, TGN Endosome–Golgi secretory traffic, 
LD formation
Arfaptin, MKLP1, PDEd, HRG4, Golgins, 
GRIP-domain proteins
7 Arl2 Cytosol, mitochondria, centro-
somes, basal bodies, cilia, RRs
Tubulin heterodimer assembly, mito-
chondrial fusion, Prenyl-protein traffic
TBCD/β-tubulin, TBCD, ELMOD1-3, 
BART/ARL2BP, PDEd, HRG4/UNC119
8 Arl3 Cytosol, centrosomes, cilia, mi-
totic spindle, midbody, Golgi
Cytokinesis, Prenyl- and Myr-protein 
traffic
PDE6δ, HRG4/UNC119, Golgins, 
ARL13B, BART/ARL2BP
9 Arl4a Cytosol, nucleus, TGN, endo-
somes, PM
Endosome–Golgi traffic, actin 
remodeling, cell migration
ELMO, GCC185, Robo1, Cytohesin2
10 Arl4c Cytosol, nucleus, PM Cholesterol traffic, filopodia, cell 
migration, tumorigenesis
α-Tubulin, filamin-A, Cytohesin2
11 Arl4d Cytosol, mitochondria, nucleus, 
PM, actin
Actin remodeling, neurite outgrowth HP1, importin-α, Cytohesin2,
12 Arl5a Nucleus Endosome–Golgi traffic HP1α, GARP, Ragulator
13 Arl5b Nucleus Endosome–Golgi traffic HP1α, GARP, Ragulator
14 Arl5c
15 Arl6 Cilia BBSome, Sec61β
16 Arl8a Lysosomes, phagolysosomes Lysosomal traffic and fusion SKIP-kinesin1b, HOPS complex
17 Arl8b Lysosomes, phagolysosomes Lysosomal traffic and fusion SKIP-kinesin1b, HOPS complex
18 Arl9
19 Arl10 Nuclei, mitochondria
20 Arl11 p-ERK
21 Arl13a
22 Arl13b Cilia, EE, CDRs, centrosomes Regulation of ciliary formation/main-
tenance, axoneme, Hh signaling, EEs
ARL3, INPP5E, PDE6δ, tubulin, FIP5, 
UBC9, MYH9
23 Arl14
24 Arl15 Cytosol, Golgi Genetic links to adiponectin levels 
and type 2 diabetes
ASAP2
25 Arl16 Cytosol, mitochondria, nucleus, 
cilia
RIG-I
26 Arfrp1 trans-Golgi Recruitment of Arl1 and 
Golgin-97/245 to trans-Golgi
Sec7-1, Cytohesin
27 Sar1a ER
28 Sar1b ER
29 Trim23 Lysosomes, Golgi, 
autophagosomes
Ubiquitin ligase, viral infection, 
membrane trafficking
UBE2D2, TBK1, Cytohesin1
National Center for Biotechnology Information (NCBI) gene names are listed, along with cellular localization, identified functions, and protein interactors. Abbrevia-
tions used include CDR, circular dorsal ruffles; EE, early endosomes; PLD, phospholipase D; PM, plasma membrane; RE, recycling endosomes; RRs, rods and rings. 
Additional information is included in Supplemental Table I.
TABLE 1: Human ARF family GTPases.
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as “molecular switches” by interconverting between inactive (GDP-
bound) and active (GTP-bound) conformations. Upon binding GTP, 
the activated GTPases alter their conformations, which increases 
their affinity for effectors and can alter their localization in cells, each 
of which contributes to the generation of a specific biological out-
put. Activated (GTP-bound) ARF family GTPases propagate their 
effects through a specific redistribution of effectors (e.g., recruit-
ment to a membrane), allosteric activation of effector enzymatic 
activity, conformational changes within the effector resulting in in-
creased affinity for other cellular components (proteins, lipids, etc.), 
or a combination of such changes. As a consequence, the signal 
output of these GTPases is tightly controlled by the regulated bind-
ing of GTP and the half-life of the activated state. These are in turn 
controlled by the stimulation of the release of bound GDP (to allow 
GTP to bind spontaneously) by guanine nucleotide exchange 
factors (GEFs) and of their intrinsic GTPase activity by GTPase- 
activating proteins (GAPs) (Casanova, 2007; Inoue and Randazzo, 
2007; Randazzo et al., 2007; Bui et al., 2009; Spang et al., 2010; East 
and Kahn, 2011; Wright et al., 2014; Vitali et al., 2017). Thus, the 
triad of GEF–GTPase–GAP can be viewed as a minimal component 
in signaling pathways that alter a large fraction of cellular behaviors. 
Yet, despite their clear importance in cell biology and links to human 
pathologies, our understanding of the pathways involved and mole-
cular mechanisms remain fragmentary. In this review, we briefly sum-
marize the known roles of the ARF family GTPases, their GEFs and 
GAPs, their localization in cells, and their interactors. Rather than 
describing in detail any one of the many pathways in which they 
operate, we instead emphasize the extensive overlap in specificities 
and actions between family members, as this represents the largest 
challenge to achieving a deep understanding of their mechanisms 
of action. Because every pathway requires the minimum GEF–
GTPase–GAP triad, we argue for a systematic approach to study 
each family and the three families together. We end our review by 
highlighting some key questions and challenges in ARF signaling, 
and hope that it inspires more collaborative efforts to address the 
large, complex, but vitally important area of ARF signaling.
ARF FAMILY GTPASES
Families of ARF GTPases and their cellular functions
Included within the ∼30 members of the mammalian ARF family are 
the six “true ARFs” (humans lack ARF2, thus the discrepancy be-
tween this number and Table 1), the 21 ARF-like (ARL) proteins, two 
SARs, and Trim23 (Table 1; additional information included in Sup-
plemental Table I) (Li et al., 2004; Kahn et al., 2006). The six mam-
malian ARFs are highly conserved, sharing > 65% sequence identity, 
and perform similar and/or overlapping functions. ARLs are more 
divergent, sharing typically 40–60% identity, and largely perform 
distinct cellular functions. The two mammalian SARs share ∼90% 
GEF Localization Function(s) Interactors
1 Arfgef1/BIG1 TGN, sorting endosomes Activation of Arf1/3, recruitment of 
AP1/AP3, myelination
Arl1, Arf1/3, ARF4/5
2 Arfgef2/BIG2 TGN, sorting endosomes Activation of Arf1/3, recruitment of 
AP1/AP3
Arl1, Arf1/3, ARF4/5
3 Cyth1 PM Cell adhesion/migration, integrin 
regulation
GRASP/tamalin, CNKSR1-3, CASP, 
Arl4A, Arl4D, Arf6
4 Cyth2/ARNO PM, REs, Ruffles Cell adhesion/migration, integ-
rin regulation, actin remodeling, 
endosome traffic
GRASP/tamalin, CNKSR1-3, CASP, 
Arl4A, Arl4D, Arf6, paxillin, RLIP76, 
β-arrestin, pallidin
5 Cyth3/ARNO3/GRP1 PM, (Glut4-positive) 
endosomes
Glut4 exocytosis, cell migration GRASP/tamalin, CNKSR1-3, CASP, 
Arl4A, Arl4D, Arf6
6 Cyth4
7 GBF1 Golgi Membrane traffic at cis-Golgi p115, Rab1b, COG4, γ-COP, 
GGA1-3, ATLG, Gmh1
8 Iqsec1/BRAG2/GEP100 PM Integrin endocytosis/cell adhesion 
regulation of AMPA receptor traffic
Calmodulin, MAP4K4, Arf5, Arf6
9 Iqsec2/BRAG1 PSDs Regulation of AMPA receptor 
traffic
Calmodulin, PSD95, IRSp53, Arf6
10 Iqsec3 PSDs Regulation of GABAergic synapse 
formation
Calmodulin, gephyrin, Arf6
11 Psd/EFA6 PM, tight junctions, 
axons, PSDs, endosomes
Tight junction formation, epithelial 
lumen formation
α-Actinin-1, 4, Arf6
12 Psd2/EFA6C
13 Psd3/EFA6D
14 Psd4/EFA6B PM, epithelial tight 
junctions
Tight junction formation, epithelial 
lumen formation
α-Actinin-1, 4, Arf6
15 Fbox8
NCBI gene names are listed, along with cellular localization, identified functions, and protein interactors. Abbreviations used include PM, plasma membrane; PSD, 
postsynaptic densities, RE, recycling endosomes; TGN, trans-Golgi network. Additional information is included in Supplemental Table II.
TABLE 2: Human ARF GEFs.
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primary sequence identity (but < 30% to any other family member), 
and have a specialized role in traffic from the endoplasmic reticulum 
(ER) to the Golgi. The ARF family GTPases are distinct from the other 
families of small, regulatory GTPases (RAS, RHO, RAB) in having an 
N-terminal extension of ∼14 amino acids and covalent modifications 
at or near this end. All six ARFs are N-myristoylated, while ARLs are 
GAP Localization Function(s) Interactors
1 Arfgap1 Golgi ER protein retrieval γ-Adaptin (AP-1), KDEL receptor/
ERD2, p24
2 Arfgap2 Golgi
3 Arfgap3 TGN, EEs EE–LE transport of M6PR and EGFR γ-COP (COPI), GGA1/2
4 Acap1/CENTB1 Rab11 REs Integrin and TfnR recycling β1-Integrin, TfnR, clathrin heavy 
chain
5 Acap2/CENTB2 PM, phagocytic cup, ARF6 
endosomes
Neurite outgrowth, FcγR-mediated 
phagocytosis
Rab35
6 Acap3/CENTB5 Neurite outgrowth, neuronal 
migration
7 Adap1/CENTA1 Membrane ruffles, mito-
chondria, dendrites, synapse
Salmonella invasion, beta2-
AR internalization, dendritic 
differentiation
Kif13b
8 Adap2/CENTA2
9 Agap1 AP-3 endosomes Endosome–lysosome transport AP-3, Kif2A
10 Agap2/PIKE FAs, Rab4/AP-1endosomes Cell migration, neurite outgrowth, 
invasion, TfnR recycling
FAK, RACK1, Akt, Homer, AP-1
11 Agap3 Endosomes
12 Agfg1/HRB, RIP Clathrin/AP-2/EPS15 
vesicles
TfnR endocytosis, HIV-1 replication Rev
13 Agfg2
14 Arap1 EEs, CDRs, podosomes EGFR endocytosis, macropinocyto-
sis, secretory lysosomes
CIN85, AP-3
15 Arap2 FAs, APPL EEs FA turnover, SF formation, integrin 
endocytosis
RhoA, Arf6, APPL1
16 Arap3 Podosome-like adhesions Cell migration, invasion, RhoGAP 
stimulation
Rap1, RhoGAP
17 Asap1 PM, FAs, podosomes/inva-
dopodia, CDRs
Cell migration, invasion, SF forma-
tion, integrin and EGFR recycling
FAK, Crk, CrkL, Src, cortactin, 
NM2A, PRKD2, CIN85, CDAP
18 Asap2 Cell periphery, phagocytic 
cup
Cell migration, FcγR-mediated 
phagocytosis
Selenoprotein K
19 Asap3 PM, CDRs Cell migration, integrin recycling, 
invasion
Grb2
20 Git1 FAs, SNX27 endosomes, 
REs, EEs
Cell migration, invasion, EGFR 
traffic/degradation
PIX, Arf6, paxillin, MEK1, FAK, 
SNX6
21 Git2 PM, FAs Cell migration, invasion, beta2-
Adrenergic R down-regulation
Vav2, paxillin, GRKs
22 Smap1 PM TfnR endocytosis Clathrin heavy chain
23 Smap2 EE, TGN EE–TGN transport Clathrin heavy chain, CALM
24 ELMOD1 Golgi, nuclear speckles, LDs
25 ELMOD2 ER, mitochondria, LDs, cen-
trosomes, RRs
Mitochondrial fusion ARL2, other ARF family GTPases
26 ELMOD3 PM, actin, lagging edge
27 RP2 PM, microtubules, nucleus Ciliary traffic ARL3, UNC119, G protein β1
NCBI gene names are listed, along with cellular localization, identified functions, and protein interactors. Abbreviations used include CDR, circular dorsal ruffles; 
EE, early endosomes; EGFR, epidermal growth factor receptor; FA, focal adhesions; LD, lipid droplets; LE, late endosomes; PM, plasma membrane; RE, recycling 
endosomes; RRs, rods and rings; SF, stress fibers. Additional information is included in Supplemental Table III.
TABLE 3: Human ARF GAPs.
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myristoylated (e.g., ARL1), palmitoylated (e.g., ARL13B), or acety-
lated (e.g., ARFRP1), with each modification critical for activity. In 
this section, we summarize briefly the actions of the different ARF 
GTPases. This should not be taken as an exhaustive description of 
their actions, and we apologize to the many researchers whose work 
is not included in the interest of space.
The ARFs are best known for their roles in recruitment of coat 
proteins/complexes and initiation of vesicle formation in membrane 
trafficking, particularly at the Golgi. However, a brief glance at 
Figure 1, which depicts localizations for all ARF family members, as 
well as the known GEFs and GAPs, reveals far more complexity in 
locations and presumed functions. ARFs are found not only in all 
regions of the Golgi, but also at the plasma membrane (PM), endo-
somes, lipid droplets, and midbodies. ARFs often show overlapping 
distribution (e.g., ARF1, 4, and 5 localize to the cis-Golgi), and one 
ARF can localize to multiple sites (e.g., ARF1 can be recruited to the 
Golgi, lipid droplets, and the PM; however, it is likely that a large 
cytosolic pool remains). ARFs have both redundant and distinct 
functions, as seen in studies showing that small interfering RNA–me-
diated knockdown of any one ARF1/3/4/5 yielded no obvious phe-
notypes, while each double knockdown of distinct pairs of these 
GTPases resulted in specific phenotypes (Volpicelli-Daley et al., 
2005). ARFs affect cellular processes by recruiting effectors. The 
term “effector” is used herein to indicate a protein that binds pref-
erentially to the activated (GTP-bound) form, resulting in a signal or 
output that changes some aspect of cell biology. There are more 
than 20 known ARF effectors and most of these are essential com-
ponents in membrane traffic in all cells (Table 1). The best-character-
ized ARF effectors are adaptors for coat proteins or the coat pro-
teins themselves, including both monomeric (e.g., GGAs or MINTs) 
(Boman et al., 2000; Dell’Angelica et al., 2000; Hill et al., 2003) and 
FIGURE 1: Subcellular localization of the ARF family GTPases, ARF GEFs, and ARF GAPs. A 
schematic cell with organelles (in red) showing the localization of the GTPases (in light blue), 
GEFs (in purple), and GAPs (in green). More detailed information for these localizations is 
provided in references cited in the text.
oligomeric complexes (e.g., COPI, AP-1, 
AP-3, and AP-4) (Serafini et al., 1991; 
Stamnes and Rothman, 1993; Traub et al., 
1993; West et al., 1997; Ooi et al., 1998; 
Hirst et al., 1999; Drake et al., 2000; Donald-
son and Jackson, 2011). ARFs also recruit 
non-coat proteins to membranes (e.g., gol-
gin-160, GCC88) (Derby et al., 2004; Gilbert 
et al., 2018) and can activate lipid-modifying 
enzymes (e.g., phospholipase D, PI(4) 
5- kinase) (Brown et al., 1993; Cockcroft 
et al., 1994; Honda et al., 1999; Jones et al., 
2000) and/or lipid transporters (e.g., FAPP1) 
(Godi et al., 2004). ARF1, ARF3, and ARF6 
are implicated in cell division and/or cytoki-
nesis, but the effectors involved remain to 
be identified (Altan-Bonnet et al., 2003; 
Hanai et al., 2016; Nakayama, 2016). ARF6 
appears to act predominantly in the cell pe-
riphery, where it regulates both endosomal 
recycling and cortical actin dynamics, which 
are also linked to RAC GTPase signaling 
(Donaldson, 2003; Schweitzer et al., 2011).
ARLs localize to and have functions in 
processes involving tubulin/microtubules at 
centrosomes, spindles, midbodies, basal 
bodies, and cilia (Figure 1). ARLs are much 
more divergent in action, with some ARLs 
functioning in parallel with those of the 
ARFs in membrane traffic, while others reg-
ulate completely different processes. For 
example, ARL1 is most closely related to ARFs in primary sequence, 
localizes to the trans-Golgi network (TGN), and acts in membrane 
trafficking through its ability to recruit proteins to that site (Yu and 
Lee, 2017). At the TGN, ARL1 effectors include BIG1 (an ARF GEF), 
Golgin-97, and Golgi-245. ARL1 also localizes to sorting endo-
somes, where it recruits BIG1 to activate ARF1 and ARF3 (D’Souza 
et al., 2014). In yeast, GTP-bound ARL1 is located at the Golgi com-
plex and facilitates the exit of vesicles from the TGN (Munro, 2005). 
In mammalian cells, ARL1 is involved in cell polarity (Lock et al., 
2005); innate immunity (Murray and Stow, 2014); and the secretion 
of insulin (Gehart et al., 2012), chromogranin A (Cruz-Garcia et al., 
2013), and matrix metalloproteinases (Eiseler et al., 2016). In marked 
contrast, ARL2 localizes to multiple cellular sites to perform surpris-
ingly distinctive functions. ARL2 is found in 1) cytosol, as a 1:1:1 tri-
mer with the tubulin cochaperone cofactor D (TBCD) and β-tubulin, 
and is required for αβ-tubulin biogenesis (Francis et al., 2017a,b); 
2) the mitochondrial intermembrane space, where it promotes mito-
chondrial fusion (Newman et al., 2014, 2017); 3) at centrosomes 
(Zhou et al., 2006); 4) in the nucleus; and 5) at rods and rings, which 
are implicated in guanine nucleotide metabolism (Schiavon et al., 
2018). Despite its involvement in such disparate activities, ARL2 is 
ubiquitously expressed in eukaryotes and has not duplicated into 
paralogues that might allow separation of functions (Francis et al., 
2016). One intriguing hypothesis born from these observations is 
that the use of a shared cell regulator at multiple locations might 
serve as a means of communication between those sites, a phenom-
enon termed “higher-order signaling” (Francis et al., 2016).
ARL2 and ARL3 display both overlapping and distinct actions 
and interactions (Van Valkenburgh et al., 2001; Zhou et al., 2006). 
Both are linked to microtubules, localize to centrosomes, and share 
the ability to bind PDEδ in a GTP-dependent manner and promote 
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the release of isoprenylated cargoes (Van Valkenburgh et al., 2001; 
Ismail et al., 2011). While they both also bind HRG4, only ARL3 
binding results in the release of N-myristoylated cargoes from this 
carrier (Ismail et al., 2012). ARL2 is involved in tubulin heterodimer 
biogenesis, while ARL3 functions in cytokinesis (Zhou et al., 2006). 
ARL3 also appears to act at the Golgi, though how such action may 
be integrated with its other roles remains unclear (Zhou et al., 2006). 
ARL3 is essential in photoreceptor cells that employ an elaborate 
variation of cilia in outer segments (Panic et al., 2003; Zhou et al., 
2006; Hanke-Gogokhia et al., 2018) (Table 4). An unexpected find-
ing is that ARL3 is activated by ARL13B (Gotthardt et al., 2015; 
Ivanova et al., 2017), which raises the possibility that other ARLs may 
also serve as ARL GEFs, particularly as so few ARL GEFs have been 
identified to date.
Primary cilia are a major site of action for four different ARLs: 
ARL3, 6, 13B, and 16 (Figure 1). Each of these GTPases plays a criti-
cal role(s) in ciliary biology, with details and mechanisms still under 
investigation. Their activity is particularly important during develop-
ment (Zhang et al., 2013), as mutations in these genes cause ciliopa-
thies and developmental disorders in mammals (Chiang et al., 2004; 
Caspary et al., 2007; Wiens et al., 2010; Liew et al., 2014; Alkanderi 
et al., 2018) (Table 4). Although best known for its role in cilia and in 
Hedgehog signaling, ARL13B also functions outside the cilium by 
interacting with a kinesin to facilitate axon guidance (Higginbotham 
et al., 2012; Casalou et al., 2014). ARL13B is also distinctive, as it is 
nearly twice the size of other GTPases in the ARF family, having a 
C-terminal domain as large as the GTPase domain. ARL6 also goes 
by the name BBS3, as its mutation is linked to Bardet-Biedl syn-
drome and defects in Wnt signaling (Chiang et al., 2004; Wiens 
et al., 2010; Zhang et al., 2011). ARL6 acts in ciliary trafficking 
through recruitment of the BBSome complex (Jin and Nachury, 
2009; Jin et al., 2010; Ye et al., 2018).
The theme of ARF GTPases sharing a similar function is evident 
in the recruitment of Golgins to the Golgi. As mentioned earlier, 
ARFs recruit Golgin-160 and GCC88 to the Golgi, while ARL1 re-
cruits Golgin-97 and Golgin-245 (Derby et al., 2004). This is just one 
of several examples in which ARLs and ARFs act in a common 
pathway. However, ARL4A, which performs a similar function by in-
teracting with GCC185 at the TGN to modulate the integrity of the 
Golgi, also has a completely distinct function in endosome-to-Golgi 
transport (Lin et al., 2011). ARL4A also plays a role in actin cytoskel-
eton rearrangement involving ELMO/DOCK180-induced RAC 
signaling (Patel et al., 2011). ARL4C and ARL4D modulate actin 
remodeling and cell migration through their interacting partners, 
filamin-A and Cytohesin 2, respectively (Li et al., 2007; Chiang et al., 
2017). Expression of ARL4C in normal epithelial cells promotes 
migration and proliferation, indicating a role in epithelial morpho-
genesis (Matsumoto et al., 2014). Each ARL4 paralogue can recruit 
the ARF GEF Cytohesins to the PM (Hofmann et al., 2007; Li et al., 
2007). ARL5 localizes to the Golgi and influences endosome–Golgi 
traffic through interactions with the GARP complex (Rosa-Ferreira 
et al., 2015), while ARL8 also acts in vesicular trafficking, predomi-
nantly at lysosomes, where it can influence the motility of this organ-
elle (Khatter et al., 2015). With the exceptions of ARL2 and ARL3, 
which act in cytosol to affect the assembly and dynamics of microtu-
bules and centrosomes, almost all ARFs and ARLs act at membranes. 
(Though nothing is currently known about the locations and func-
tions of ARLs 9, 11, 14, or 15.)
Activated ARF-related protein 1 (ARFRP1) also localizes to the 
TGN and has been implicated in vesicular trafficking of vesicular 
stomatitis virus G protein (Shin et al., 2005; Nishimoto-Morita et al., 
2009), glucose transporters (Hesse et al., 2012), and other PM G
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proteins. ARL1 and its effectors Golgin-97 and Golgin-245 are re-
cruited to the TGN by ARFRP1 (Setty et al., 2003; Zahn et al., 2006). 
In addition to acting in membrane trafficking, ARFRP1 also plays 
roles in regulating metabolism, especially lipid and fat storage. 
Knockout of Arfrp1 in different mouse tissues causes severe meta-
bolic defects (Hommel et al., 2010; Jaschke et al., 2012; Rodiger 
et al., 2018) (Table 4). Despite their similarities to ARFs and ARL1, 
neither GEFs nor GAPs for ARFRP1 have been identified, making 
descriptions of pathways challenging.
Two members of the ARF family are much larger than the 20- to 
25-kDa norm, ARL13B with 428 residues and Trim23/ARD1 with 574 
residues (Supplemental Table I). Homologues of the C-terminal do-
main of ARL13B are not found in other proteins, and we have little 
information on its function, save the presence of a VXPX ciliary lo-
calization motif. Trim23 is a multidomain protein having a RING fin-
ger, two B-boxes, and a coiled-coil motif (thus a tripartite motif 
[TRIM]) (Vichi et al., 2005). These domains have polyubiquitination 
activity and act in the antiviral defense system and adipocyte dif-
ferentiation (Arimoto et al., 2010; Watanabe et al., 2015; Sparrer 
et al., 2017).
The functions and mechanisms of SARs are well characterized. 
SAR1 is activated by the Sec12 GEF, leading to its recruitment to 
the site of protein export from the ER, ERES (ER exit sites) (Figure 
1). Activated SAR1 recruits the Sec23/24 complex and later the 
Sec13/31 complex to form the COPII coat necessary to generate 
COPII vesicles. The Sec13/31 complex promotes the GAP activity 
of Sec23 to “inactivate” SAR that serves to recycle all components. 
Sec12 and Sec23 are an atypical GEF and GAP pair as they lack a 
canonical GEF or GAP domain, and thus 
this regulatory system is of limited use in 
modeling mechanisms of the ARF/ARL 
GEFs and GAPs. Consequently, SARs are 
omitted from further discussion in this 
review.
Structural insight into the actions 
of ARF GTPases
While all ARF family members share the ca-
nonical G domain with nucleotide-sensitive 
switch 1 and 2 loops (Amor et al., 1994), 
they display structural signatures that strik-
ingly distinguish them from other small 
GTPase families (Figure 2) (Pasqualato et al., 
2002). The hallmark of members of the ARF 
family is an allosteric structural feature, 
which allows their nucleotide-binding site to 
communicate with regions located on the 
other side of the GTPase. It is based on an 
interswitch region (as it connects switch 1 
and switch 2), that toggles like a push but-
ton between the inactive and the active con-
formations (Yu et al., 2012). The ability of the 
interswitch to toggle is encoded in a 
conserved sequence signature at the begin-
ning of the switch 2 (Pasqualato et al., 2002). 
In toggling between these two positions, 
the interswitch simultaneously modifies the 
conformation of both the nucleotide-bind-
ing site and the other side of the protein. In 
ARF and related GTPases, the rearrange-
ment of the interswitch is coupled to a vari-
able N-terminal extension, which is autoin-
hibitory in the GDP-bound form and swings out to facilitate 
activation. In ARF GTPases, this region is a myristoylated amphipa-
thic helix that interacts with membranes through the myristoyl group 
and the neighboring residues (Antonny et al., 1997; Liu et al., 2009, 
2010). This is a prerequisite for their activation by GTP, thus coupling 
the activation of the GTPase to its interaction with the membrane 
bilayer (see also the ARF GEFs section).
Because of these major differences compared with classical RAS-
like GTPases, caution is needed when using mutants and fusions to 
manipulate the activation state of ARF GTPases. The glutamine at 
the beginning of switch 2 is generally critical for GAP-stimulated 
GTP hydrolysis (Cherfils and Zeghouf, 2013), and this is also the case 
for ARF GTPases (e.g., Q71 in ARF1 or ARL1, Q70 in ARL2) (Zhang 
et al., 1994; Van Valkenburgh et al., 2001). However, another classi-
cal mutation, a P-loop serine/threonine to asparagine substitution, 
which gives rise to a dominant-negative version in many small 
GTPases by reducing their affinity for guanine nucleotide and titrat-
ing their GEFs, may not function the same in all ARF GTPases (Macia 
et al., 2004). Alternatively, mutation of another threonine, located in 
switch 1, trapped ARF6 in a GDP-bound form, a mutation that could 
in principle also function in related ARF GTPases, many of which 
share the same structural feature. Another important aspect is that, 
given the regulatory role of the N-terminus and the need for lipid 
modifications, ARFs should be tagged only at the C-terminus, and 
even then only with caution (Jian et al., 2010).
ARFs function by binding effectors, and structural studies of 
many ARF/ARL–effector complexes show that ARFs have similar 
conformations in all complexes and bind most effectors in the 
FIGURE 2: Structural determinants of ARF association with membranes and interactors. ARFs 
have four regions that change conformation between GDP- and GTP-bound forms: the canonical 
switch 1 (in orange) and switch 2 (in magenta) that directly sense the nature of the bound 
nucleotide; the myristoylated N-terminal helix (in blue), which is autoinhibitory in ARF-GDP and 
binds the membrane in ARF-GTP; and the interswitch (in red) that functions as a push button to 
ensure allosteric communication between the membrane- and the nucleotide-binding sites. 
GEFs, GAPs, and effectors generally bind to switch 1, switch 2, and/or the interswitch by one 
domain (in light yellow) and carry other domains that bind to the membrane (in light blue). The 
membrane bilayer is denoted in gray.
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same area centered on an invariant triad of aromatic residues in 
the switch/interswitch regions (Khan and Menetrey, 2013). In con-
trast, the effectors bind ARF-GTP through binding sites that are 
distinct in primary, secondary, ternary, and quaternary structures 
(Cherfils, 2014). Thus, the solved structures of known ARF– 
effector complexes do not inform on structural determinants that 
could be used to predict the binding of other effectors to ARF/
ARLs. Interestingly, at least one ARF effector (i.e., coatamer) en-
hances the GTP hydrolytic activity of an ARF GAP, suggesting the 
formation of a ternary ARF-effector-GAP complex. Supporting 
evidence for formation of such a ternary complex is provided by 
a composite structural model for the ARF1/coatamer/ArfGAP1 
complex (Yu et al., 2012) and by the recent cryoelectron micros-
copy study of ARF1/COP1/ArfGAP complex reconstituted on a 
lipid vesicle (Dodonova et al., 2017). A common feature of ARF–
effector interactions is that they are predicted to position 
effectors in precise orientations in apposition to the membrane 
(DiNitto et al., 2007; Liu et al., 2009, 2010; Cherfils, 2014). This 
“solid phasing” will impart orientation constraints for effector 
interactions that are important to produce signals. As a conse-
quence, biochemical assays used to determine affinities for and 
activities of effectors should incorporate membranes and are 
subject to changes in response to different lipid components of 
those membranes.
Regulating ARFs
ARFs are N-myristoylated (a cotranslational covalent modification 
that is not reversible), but this modification, while critical to activity, 
is unlikely to be regulatory. Other posttranslational modifications 
(e.g., phosphorylation, ubiquitination) occur on the GTPases, GEFs, 
and GAPs, but have been largely underexplored. The details of ARF 
activation and deactivation are discussed in the ARF GEFs and ARF 
GAPs sections.
ARF GEFS
Families of ARF GEFs and their cellular functions
ARFs require GEFs to accelerate nucleotide exchange. This is 
likely true of the ARLs as well, though relatively weak affinity for 
guanine nucleotides by ARL2, ARL13B, and perhaps others sug-
gests the possibility of other means of regulating their activation 
process. As no GEFs for ARLs have been identified, except that 
of ARL13B for ARL3 (Gotthardt et al., 2015), this section is limited 
to GEFs that act on mammalian ARFs. The human genome en-
codes 15 ARF GEFs divided into six families based on sequence 
relatedness, domain organization, and phylogenetic analyses: 
GBF, BIGs, Cytohesins, EFA6/Psd, BRAG/IQSec, and FBX (Table 
2, Figure 3A, and Supplemental Table II). All ARF GEFs share a 
common catalytic Sec7 domain (Sec7d) and a mechanism of ac-
tion, but display diversity in their actions and regulation in cells 
(Peyroche et al., 1996; Cherfils and Chardin, 1999; Jackson and 
Casanova, 2000; Casanova, 2007). The locations of ARF GEFs in 
cells parallel those of ARF1-6 at the Golgi, endosomes, and the 
PM (Figure 1). In this section, we briefly describe the actions of 
human ARF GEFs.
GBF1 and BIG1/2 are key regulators of membrane traffic within 
the secretory and endosomal pathways (Wright et al., 2014). GBF1 
preferentially localizes to the Er-Golgi intermediate compartment 
(ERGIC) and the cis-Golgi, where it mediates ARF activation required 
for COPI vesicle formation. GBF1 likely activates ARF1 and ARF4, as 
only the simultaneous removal of these, but not any other pair of 
ARFs, inhibits COPI traffic (Zhao et al., 2002, 2006; Volpicelli-Daley 
et al., 2005; Szul et al., 2007; Manolea et al., 2008). GBF1 also acts 
at the TGN to support the recruitment of BIG1 and BIG2 through 
activating ARF4 and ARF5 (Lowery et al., 2013). GBF1 facilitates 
lipid droplet formation (Ellong et al., 2011; Takashima et al., 2011; 
Bouvet et al., 2013), is detected at PM sites involved in active migra-
tion and chemotaxis (Mazaki et al., 2012; Busby et al., 2017), and in 
some cells facilitates traffic through the glycophosphatidyl-inositol–
enriched endosomal compartments (GEECs) pathway (Gupta et al., 
2009), but the ARFs activated for these functions are unknown. BIG1 
and BIG2 localize to the TGN and endosomes, where they mediate 
ARF activation required for endosome–PM recycling, TGN–PM recy-
cling, TGN–late endosome transport, and in some cells TGN–gran-
ule transport (Shinotsuka et al., 2002a; Zhao et al., 2002). BIG1 and 
BIG2 facilitate the recruitment of the clathrin adaptors AP1 and AP3 
through activation of ARF1 and ARF3 (Pacheco-Rodriguez et al., 
2002; Shinotsuka et al., 2002a,b; Ishizaki et al., 2008). BIG1 seems to 
play additional nontrafficking roles, as it is detected in the nucleus of 
serum-starved cells (Padilla et al., 2004, 2008).
The Cytohesins localize to and regulate endosomal trafficking 
(Figure 1), including the stimulated recycling of the glucose trans-
porter GLUT4, integrins, and other proteins (Caumont et al., 2000; 
Oh and Santy, 2010, 2012; Li et al., 2012; Salem et al., 2015). 
FIGURE 3: Domain organization of ARF GEFs and ARF GAPs. A 
schematic of the domains present in each subfamily of the ARF GEFs 
(A) and ARF GAPs (B). The defining ARF GEF/Sec7 domain and the 
ARF GAP domain are aligned. Protein lengths are not drawn to scale. 
Abbreviations (in alphabetical order): A, ARF GAP lipid-packing sensor 
(ALPS); ANK, ankyrin repeat; BAR, Bin/Amphiphysin/Rvs; BoCCS, 
binder of coatomer, cargo, and SNARE; CALM BD, calm binding 
domain; CB, clathrin box; DCB, dimerization and cyclophilin binding; 
E/DLPPKP8, 8 repeats of this primary sequence (single letter code); 
F-BOX, cyclin F protein interaction motif; FG repeats, multiple copies 
of XXFG repeated; GLD, GTP binding protein–like domain; GRM, 
Glo3 regulatory motif; HDS(1-4), homology downstream of Sec7; 
HUS, homology upstream of Sec7; IQ, isoleucine/glutamine 
calmodulin-binding motif; PBS, Paxillin binding site; PH, pleckstrin 
homology; Pro-rich, proline rich; RA, Ras association; Rho GAP, Rho 
GTPase-activating protein; SAM, sterile α motif; SHD, Spa homology 
domain.
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Cytohesins can be recruited to the PM in response to insulin, epider-
mal growth factor (EGF), or nerve growth factor (NGF) (Venkateswarlu 
et al., 1998a,b), where they are required for signaling by these hor-
mones (Li et al., 2003; Fuss et al., 2006; Hafner et al., 2006; Lim et al., 
2010; Attar and Santy, 2013; Hahn et al., 2013; Pan et al., 2013; Re-
viriego-Mendoza and Santy, 2015). Cytohesins also stimulate Rac ac-
tivation and actin polymerization at the cell periphery (Frank et al., 
1998; Santy and Casanova, 2001; Santy et al., 2005; Li et al., 2007; 
White et al., 2010; Reviriego-Mendoza and Santy, 2015), resulting in 
increased cell migration (Santy and Casanova, 2001; Santy et al., 
2005; Torii et al., 2010; Attar and Santy, 2013). Cytohesins perform 
these functions by activating ARF1 and/or 6. However, all ARF iso-
forms are efficiently activated by Cytohesins in vitro, raising the ques-
tion of how specific ARF isoforms are selected in vivo.
The BRAGs (Brefeldin A–resistant ARF GEF, later renamed IQSecs) 
contain a calmodulin-binding IQ motif in the N-terminal third of each 
protein (Figure 3A). IQSec1 and 3 are highly enriched in the central 
nervous system, while IQSec2 is ubiquitous. IQSecs localize to endo-
somes and the PM in nonneuronal cells, and to postsynaptic densi-
ties in neurons (reviewed in D’Souza and Casanova, 2016) (Figure 1), 
In general, IQSecs appear to control the internalization of adhesive 
and/or signaling molecules. Examples include the adhesion proteins 
dumbfounded (Duf), roughest (rst), and N-cadherin in myoblasts 
(Bach et al., 2010); the semaphorin, Sema3E, and its cognate recep-
tor plexin D1 in endothelial cells (Sakurai et al., 2011); synaptic AMPA 
receptors in neuronal pathfinding (Charych et al., 2004; Scholz et al., 
2010; Elagabani et al., 2016); and β1 integrins in metastasizing breast 
cancer cells (Moravec et al., 2012). IQSecs perform these functions 
through the activation of ARF5 and/or ARF6. Like Cytohesins, IQSecs 
efficiently activate all ARFs in vitro (Peurois et al., 2017), and the 
mechanisms that determine their selectivity in cells remain elusive. 
IQSec1 also acts in the nucleus (Dunphy et al., 2007), raising the 
question of how its various functions are integrated and regulated.
The EFA6 (exchange factor for ARF6)/PSD (pleckstrin homology 
and Sec7 domain) proteins activate ARF6 and regulate actin cyto-
skeleton dynamics at the cell surface (Franco et al., 1999; Macia 
et al., 2001) (Figure 1). They appear to support distinct functions in 
specific cells and during development, as suggested by their varied 
tissue distribution (all EFA6 proteins except EFA6B are abundant in 
brain but are differentially distributed within different brain regions, 
with EFA6C showing the most selective localization to only Purkinje 
cells and the choroid plexus; Matsuya et al., 2005) and changing 
expression levels during development (Sakagami et al., 2006). EFA6 
has been implicated in dendritic branching and spine formation 
(Inaba et al., 2004) and might regulate endocytosis of neurotrans-
mitter receptors (Decressac et al., 2004). It also has been implicated 
in clathrin-mediated endocytosis through a regulatory interaction 
with endophilin (Boulakirba et al., 2014).
FBX8 is the sole representative of the last GEF subfamily and is 
the least understood (Table 2). The role of the N-terminal F-box 
domain is unclear (Figure 3B). Paradoxically, though serving as a 
GEF for ARF6 at the cell surface, it also exhibits a suppressive effect 
on ARF6 activity, perhaps through a poorly described effect on 
mono-ubiquitination of ARF6 (Yano et al., 2008). Interestingly, FBX8 
shows no GEF activity in vitro, raising uncertainty as to whether it is 
a bona fide GEF.
Structural insight into the mechanisms of ARF activation 
by GEFs
All ARF GEFs use the same mechanism to promote nucleotide ex-
change through the highly conserved, catalytic ∼200-residue Sec7 
domain (Sec7d), so named based on homology to the domain in the 
Saccharomyces cerevisiae Sec7 protein (Peyroche et al., 1996). To 
be activated by a Sec7d, ARF-GDP must be primed by membranes 
that displace the autoinhibitory N-terminal helix, thus allowing the 
GEF to promote the toggle of the interswitch and secure ARF-GDP 
on the membrane before GDP dissociation (Renault et al., 2003). 
Next, the Sec7d inserts an invariant glutamate (also called the “glu-
tamic finger”; Beraud-Dufour et al., 1998; Renault et al., 2003) into 
the active site, which competes with the phosphates of GDP to pro-
mote its dissociation and the formation of a nucleotide-free com-
plex that can bind GTP (Goldberg, 1998). Charge-reversal mutation 
of the glutamic finger renders a Sec7d catalytically inactive (Beraud-
Dufour et al., 1998). Thus, in a manner that is unique to ARF GEFs, 
stimulation of GDP/GTP exchange has an absolute requirement for 
a membrane, which can be likened to a cofactor. Interestingly, the 
Sec7d of GBF and BIG is generally, although not always, the target 
of the fungal toxin Brefeldin A, which traps an abortive ARF–GDP–
BFA–Sec7 complex (Peyroche et al., 1999; Mossessova et al., 2003; 
Renault et al., 2003).
Regulating GEFs
ARF signaling is tightly regulated in cells, implying that the activating 
GEFs are catalytically active only at specific times and places. GEFs 
are regulated by multiple molecular mechanisms that impact their 
membrane association and/or catalytic activity. All inactive ARF GEFs 
are cytosolic, but activate ARF only on membranes, suggesting that 
membrane recruitment represents a regulatory step. Recruitment 
strategies differ among the GEFs, albeit some commonalities are 
emerging. GBF1 and BIG1/2 share a common domain architecture 
composed of domains located upstream and downstream of the 
Sec7d, coined HUS and HDS domains, respectively (Mouratou et al., 
2005). These proteins are recruited through an interaction of their 
N-terminal regions (up to the Sec7d) with a small GTPase: Rab1b for 
GBF1 (Alvarez et al., 2003; Monetta et al., 2007) and ARL1 (Christis 
and Munro, 2012; McDonold and Fromme, 2014) and ARF4/5 (Low-
ery et al., 2013) for BIG1 and BIG2. Such a system is reminiscent of 
the “cascade” of Rab GTPases working at several stages of mem-
brane trafficking (Jones et al., 1999; Stalder and Antonny, 2013). The 
C-terminal regions of GBF1 and BIG1/2 are also important, as intact 
HDS domains are required for their membrane association (Mc-
Donold and Fromme, 2014; Chen et al., 2017; Gustafson and 
Fromme, 2017; Meissner et al., 2018; Pocognoni et al., 2018). It is 
likely that multiple domains position these GEFs on the membrane, 
but how such interactions are ordered and whether or not they dis-
play cooperativity is unknown. The catalytic activity of GBF1, BIG1, 
and BIG2 appears to be regulated through allosteric mechanisms. 
The activity of the yeast Sec7p (orthologue of BIG1/2) is stimulated 
through conformational changes induced by binding of Ypt (yeast 
Rab orthologues) GTPases to its N- and C-terminal domains (Mc-
Donold and Fromme, 2014). In addition, binding of ARF-GTP also 
stimulates activity in a forward loop where the generated product 
further activates Sec7d. There are three allosteric binding sites on 
Sec7p, two for Ypts and one for activated ARF, leaving open the 
catalytic GEF site for binding ARF-GDP. Such a regulatory/stimula-
tory effect may ensure a concentrated burst of activated ARFs to lo-
cally recruit a plethora of effectors. However, mammalian BIG1/2 and 
GBF1 do not show an analogous regulatory mechanism. Instead, the 
catalytic activity of GBF1 may be stimulated by a HDS1-phos-
phoinositide (PIP) interaction (Meissner et al., 2018), analogous to 
the PH domain regulating the catalytic activity of BRAG/IQSecs.
Cytohesins, BRAG/IQSecs, and EFA6/PSDs contain a PH domain 
downstream of their Sec7 domain (Figure 3A) that facilitates 
membrane recruitment by interacting with PIPs and other anionic 
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phospholipids and, in some cases, the active forms of ARF/ARL 
GTPases. The binding properties and structural modalities, how-
ever, diverge between the families. The PH domains of Cytohesins 
play multiple roles, including specific recognition of PIP2 and PIP3 
by the canonical lipid-binding site (DiNitto et al., 2003; Cronin et al., 
2004), autoinhibition of the Sec7 active site (DiNitto et al., 2007), 
and implementation of a positive-feedback loop by binding to ARF-
GTP or ARL4-GTP (Cohen et al., 2007; Hofmann et al., 2007; Mal-
aby et al., 2013; Stalder and Antonny, 2013). An important determi-
nant is the polybasic region located immediately downstream of the 
PH domain, which contributes both to autoinhibition and recruit-
ment to the membrane. Other layers of regulation have been de-
scribed. One of these is an autoinhibitory interaction mediated by 
the N-terminal coiled coil, a domain involved in cytohesin dimeriza-
tion. Autoinhibition is relieved by AKT-dependent phosphorylation 
of a threonine residue in the PH domain, which allows the recruit-
ment of Cytohesins to membranes (Li et al., 2012; Hiester and 
Santy, 2013). Phosphorylation of protein kinase C (PKC) sites in the 
polybasic regions of Cyth1 and Cyth2/ARNO also stimulates their 
GEF activity, presumably by destabilizing the autoinhibited state 
(DiNitto et al., 2007). Grp1 lacks these PKC sites but can be phos-
phorylated by AKT on a serine near the catalytic site in the Sec7d 
and a threonine in the β1/β2 loop in the PH domain, thereby influ-
encing GEF activity and PIP affinity/specificity, respectively (Li et al., 
2012).
The PH domains of BRAG/IQSecs differ from those in Cytohesins 
in that they do not autoinhibit the Sec7 domain (Jian et al., 2012; 
Aizel et al., 2013) and they bind several anionic lipids instead of 
recognizing a single phosphoinositide with high specificity (Karan-
dur et al., 2017). PIP2 binding increases their catalytic activity, likely 
by positioning the GEF in an optimal membrane-based orientation 
with respect to the ARF GTPase (Karandur et al., 2017). In contrast 
to Cytohesins, ARF-GTP has no effect on BRAG/IQSec activity. In 
addition, BRAG/IQSecs are unique among the GEFs in their sensi-
tivity to calcium due to the noncanonical IQ motif in the N-terminus 
(Figure 3A), which fits the consensus for binding to calcium-free 
calmodulin. BRAG1/IQSec2 binds to Ca2+-free calmodulin in vitro, 
and addition of Ca2+ causes its dissociation from membranes (Aizel 
et al., 2013; Roy et al., 2016). Whether this dissociation is due to a 
calmodulin-based regulation, to competition of Ca2+ with phospho-
lipids for binding to the PH domain, or both acting in synergy re-
mains to be established but raises the question of possible cross-
talk between Ca2+ and ARF signaling.
EFA6/PSD is also recruited to anionic membranes by its PH 
domain and a polybasic element in its C-terminus, but its activity is 
inhibited by ARF-GTP, indicating negative-feedback regulation 
(Padovani et al., 2014). Its GEF activity is enhanced by direct interac-
tion with endophilin in clathrin-mediated endocytosis (Boulakirba 
et al., 2014).
ARF GAPS
Families of ARF GAPs and their cellular functions
ARF GAPs are defined by the presence of the conserved, catalytic 
GAP domain (Figure 3B), first identified in ArfGAP1, which binds to 
ARF-GTP to promote hydrolysis of GTP to GDP. The human genome 
encodes at least 28 proteins containing an ARF GAP domain or hav-
ing GAP activity (Gillingham and Munro, 2007; Kahn et al., 2008; 
Donaldson and Jackson, 2011) (Table 3; additional information in-
cluded in Supplemental Table III). There are eight additional ARF 
GAP genes on chromosome 10, but it is not known whether these 
are expressed. ARF GAPs are divided into 10 subtypes based on 
sequence similarity and shared domain structure (Figure 3B) 
(Randazzo and Hirsch, 2004; Inoue and Randazzo, 2007; Spang 
et al., 2010). Each GAP subtype, and even members within a par-
ticular subtype, display distinct localizations (Figure 1) and functions, 
and those can be either ARF dependent or ARF independent 
(Gillingham and Munro, 2007; Spang et al., 2010; Donaldson and 
Jackson, 2011; Vitali et al., 2017). An exception is the ELMOD family 
proteins that lack the ARF GAP domain, yet have in vitro activity 
against a wide range of ARF family GTPases, including both ARFs 
and several ARLs (Bowzard et al., 2007; East et al., 2012; Ivanova 
et al., 2014). The three mammalian proteins, ELMOD1-3, share an 
ELMO domain and an apparent catalytic arginine (East et al., 2012). 
Their cellular locations are shown in Figure 1, but are not discussed 
further.
With the well-established role of ARFs in membrane trafficking, 
most studies of ARF GAPs focused in this area, and specifically in 
coat/adaptor recruitment to membranes, predominantly at the 
Golgi and PM (Gillingham and Munro, 2007; Spang et al., 2010; 
Donaldson and Jackson, 2011; Shiba and Randazzo, 2012; Vitali 
et al., 2017). At least six subtypes of GAPs are involved in the recruit-
ment of ARF-dependent adaptors, including the COPI coatomer, 
GGAs, and clathrin and its adaptor AP-3. Because GAPs can inacti-
vate ARFs, the early models posited that GAPs function exclusively 
as terminators of ARF signaling (Weimer et al., 2008). However, the 
role of GAPs is far more complex. Compelling evidence for function 
of GAPs in supporting ARF activities, rather than solely acting as 
signal terminators, initially came from a screen for high-copy sup-
pressors of ARF insufficiency in yeast that showed that all ARF GAPs 
in that organism could compensate for the ARF deficiency (Zhang 
et al., 1998). The idea of GAPs being involved in propagation of an 
ARF signal was further supported by the finding that a number of 
GAPs drive coat assembly and cargo selection during the formation 
of transport vesicles (Yang et al., 2002; Lee et al., 2005; Spang et al., 
2010; Bai et al., 2011; Shiba et al., 2011). These observations sug-
gest that GAPs can serve as ARF effectors, or that ARF activity re-
quires multiple rounds of inactivation/activation cycles that require 
GAPs, or both.
ARF GAPs also regulate the actin cytoskeleton and associated 
adhesive structures (Hoefen and Berk, 2006; Randazzo et al., 2007; 
Ha et al., 2008; Casalou et al., 2016; Zhou et al., 2016; Luo et al., 
2017; Vitali et al., 2017); for example, at least seven GAPs (GIT1, 
GIT2, ASAP1-3, ARAP2, and AGAP2) associate with focal adhesions 
(FAs) and function therein (Figure 1; listed under PM in this figure to 
save space). GAP effects are mediated in part by regulating traffic of 
FA components to the nascent structures and through effects on 
RHO GTPase signaling, including acting as scaffolds for compo-
nents in the Rho family GTPase pathways (Zhao et al., 2000; Lamorte 
et al., 2003; Yin et al., 2005; Frank et al., 2006) and directly binding 
to and altering the functions of actin, non-muscle myosin 2 (Chen 
et al., 2016), and Kif2A (Luo et al., 2016). Some effects on the 
cytoskeleton can be propagated by GAP mutants lacking catalytic 
activity but able to bind ARF-GTP (Randazzo et al., 2000), again 
supporting the role of GAPs as effectors rather than simply signal 
terminators. Some GAPs (e.g., ARAPs) contain both ARF GAP and 
RHO GAP domains, with functions that can be attributed to either 
activity (Miura et al., 2002; Krugmann et al., 2002; Stacey et al., 
2004; Nishiya et al., 2005; Yoon et al., 2006, 2008; Gambardella 
et al., 2011, 2012; Chen et al., 2013, 2014; Luo et al., 2018).
ARF GAPs also affect the activities of protein kinases (e.g., 
AGAP2 binds and activates AKT; Liu et al., 2007; while ARAP2 re-
duces AKT phosphorylation, and thereby its activity, by an unknown 
mechanism; Luo et al., 2018). Thus, a single ARF GAP can affect 
multiple signaling pathways, and multiple ARF GAPs may impinge 
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on a single pathway. Unfortunately, our knowledge of the many 
functions in signaling and integration of multiple signaling pathways 
to elicit distinct phenotypic responses is still fragmentary.
Structural insight into the mechanisms of ARF GAPs
Soon after the discovery of the first ARF GAP (Cukierman et al., 
1995), the role of the catalytic arginine (aka an “arginine finger”; 
Ahmadian et al., 1997; Scheffzek et al., 1998; Cherfils and Zeghouf, 
2013) in the hydrolysis of the β-γ phosphate bond by the ARF was 
established (Randazzo et al., 2000). The use of a highly conserved, 
catalytic arginine in GAP-stimulated GTP hydrolysis is also present 
in RHO GAPs (Barrett et al., 1997; Amin et al., 2016). Similar to 
many GAPs, the ARF GAP domain inserts the arginine finger into 
the nucleotide-binding site to stabilize the transition state of the 
reaction, and this requires the conserved glutamine in the switch 2 
region (Ismail et al., 2010; Cherfils and Zeghouf, 2013). Loss of 
GAP activity upon mutation of the arginine finger is fully consistent 
with its catalytic function. The arginine finger mechanism appears 
to be shared by both the ARF GAPs and ELMOD1-3, despite their 
disparate structures (East et al., 2012). Calcium stimulates the in 
vitro GAP activity of ASAP but not of other GAPs, while also com-
peting with its association to the membrane, again raising the 
intriguing issue of cross-talk between Ca2+ and ARF signaling 
(Ismail et al., 2010).
Regulating ARF GAPs
Membranes play a central role in regulating ArfGAPs, by restricting 
both their activities to specific subcellular locations and allosteric 
control of their GAP activity. Recruitment to membranes and 
allosteric activation of GAPs is commonly conferred by their PH 
domains, which are N-terminal to the GAP domains; this is true for 
the ASAP, ACAP, ARAP, and AGAP subfamilies (Kam et al., 2000; 
Nie et al., 2002; Campa et al., 2009; Jian et al., 2015) (Figure 3B). 
Other domains also contribute to regulating GAP activity. The 
curvature-sensing BAR domain of ASAP1 positions an autoinhibi-
tory motif to contact the PH and GAP domains, thus inhibiting 
GAP activity (Jian et al., 2009), while a BAR domain binding part-
ner, NM2A, stimulates ASAP1 activity, perhaps by relieving the 
autoinhibition (Chen et al., 2016). In a landmark study of ArfGAP1, 
recognition of membrane curvature by an ALPS motif, a peptide 
that folds as a helix to bind curved membranes, was shown to 
stimulate its GAP activity (Bigay et al., 2005). The catalytic activity 
of ArfGAP1 and ArfGAP2 also can be allosterically regulated by 
coatomer and cargo binding (Goldberg, 2000; Luo and Randazzo, 
2008; Luo et al., 2009). In another example, nonmuscle myosin 2A 
stimulates ASAP1 activity, perhaps by relieving autoinhibition 
(Chen et al., 2016).
For several ARF GAPs that function in FAs, including GITs, 
ASAP1, and AGAP2, targeting is achieved by binding to specific FA 
components (Turner et al., 2001; Randazzo et al., 2007; Vitali et al., 
2017). ARF GAPs that regulate the Golgi and endocytic compart-
ments also are targeted by binding to vesicle coat proteins, includ-
ing SMAPs binding through clathrin boxes to clathrin heavy chain 
and ArfGAP1 binding the δ-COP component of COPI coatomer 
(Tanabe et al., 2005; Natsume et al., 2006; Weimer et al., 2008; 
Spang et al., 2010; Suckling et al., 2015). These studies highlight the 
general principle, in which membrane and protein features that de-
fine the environmental conditions are coupled to the regulation of 
the GAP activity. They also show that specific mechanisms are re-
markably diverse, likely to allow diverse ARF functions, and the 
need to unravel these mechanisms to allow a clear understanding of 
ARF GAP functions in cells.
EVOLUTIONARY PARALLELS BETWEEN ARF GTPASES 
AND THEIR GEFS AND GAPS
The complexity of human ARF GTPases and their GEFs and GAPs 
presents a major challenge in defining their functionalities. An 
evolutionary approach can help by categorizing the proteins based 
on their evolutionary history and presence or absence in different 
organisms with diverging cell biologies (Figure 4A). It can also help 
to connect the human complement to that of other model (and 
nonmodel) organisms by detailing how the diversity of the human 
proteins arose. Functional diversity can most easily be conceptual-
ized as arising at three levels: 1) vertebrate-specific machinery that 
arose in the lineage giving rise to animals, 2) machinery present in 
the common ancestor of all eukaryotes, and 3) machinery present 
in the archaeal contributor to the origin of eukaryotes. The human 
complement of proteins in these three families includes a large 
number of subfamilies, shared among vertebrates, for example, 
humans, mice, rats, and fish. These are largely explained by the 
series of whole-genome duplications that took place at the dawn 
of vertebrates and gave rise to ARFs 1-5 (Manolea et al., 2010), 2-3 
paralogues in all ARF GAPs (except for ArfGAP1; Schlacht et al., 
2013), and 2-4 paralogues in almost all ARF GEFs (Figure 4B and 
Tables 2 and 3). The human complement also partly reflects expan-
sion of the families in the lineage that gave rise to animals, whether 
at the ancestor of all animals (i.e., holozoan) or of animals plus 
fungi (i.e., opisthokont). Examples include the duplication that 
gave rise to class I versus class II ARFs in holozoans (Manolea et al., 
2010), the emergence of the GAP ASAP (Schlacht et al., 2013), or 
that of the GEF EFA6, each of which arose in the opisthokonts (S. 
V. Pipaliya, A. Schlacht, C. M. Klinger, R. A. Kahn, and J. Dacks, 
personal communication). These are quite ancient (arising around 
a billion years ago; Eme et al., 2014), but still reflect ARF and regu-
latory machinery that is restricted to a relatively limited subset of 
eukaryotes, later expanded in vertebrates. We share these 
proteins with basal animal lineages and fungi, meaning that mole-
cular cell biological data from model organisms (e.g., Drosophila 
melanogaster, Caenorhabditis elegans, and S. cerevisiae) can 
meaningfully be applied to understand these proteins in human 
cells. However, there are no orthologues of these proteins in other 
eukaryotes, including plants, which likely reflects important func-
tional differences.
To understand ARF signaling and regulatory biology common to 
all eukaryotic organisms, we need to look for proteins that arose 
before the common ancestor of all eukaryotic life (around 2 billion 
years ago; Eme et al., 2014) and contributed common machinery in 
its descendent lineages. We know that this last eukaryotic common 
ancestor (LECA) was sophisticated, possessing a complement of 
membrane trafficking machinery that rivals that found in many eu-
karyotes today. LECA contained 16 ancient ARF GTPases, two of 
which were true ARFs (R. Petrželková and M. Eliáš, personal com-
munication). It also had six ARF GAPs (SMAP, AGFG, ArfGAP1, Arf-
GAP2, ACAP, ArfGAP_C2; Schlacht et al., 2013) (Figure 4A). This last 
protein is absent from human and yeast, but present in other 
eukaryotic lineages like plants and plant pathogens such as Phytop-
thora. The existence of ArfGAP_C2 highlights the fundamental 
eukaryotic cell biology left to be discovered, especially that not 
present in mammals. The LECA also possessed at least two 
ELMOD GAPs, which work on both ARFs and ARLs (East et al., 2012) 
(Figure 4A). GBF1 and BIG were also present in the LECA (Bui et al., 
2009), as was Cytohesin (S. V. Pipaliya et al., personal communica-
tion). Clearly, the complexity of ARF signaling had already been well 
developed at the dawn of eukaryotes. Recently, it has been possible 
to dig even deeper into the origins of ARFs with the discovery of 
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the Asgard archaea, metagenomic assemblies of what appear to 
be the closest living descendants of the archaeal lineage that 
contributed to the birth of eukaryotes (Spang et al., 2015; 
Zaremba-Niedzwiedzka et al., 2017). Within these genomes can 
be found GTPases that are not ARFs, ARLs, or SARs, but are 
clearly close relatives of the GTPases from which the ARF family 
later arose (Spang et al., 2015; Klinger et al., 2016). Examples of 
some proteins with domains similar to possible ARF GAPs and 
GEFs were also found, in some cases fused to the GTPases 
themselves.
Defining evolutionary patterns for the ARF, GEF, and GAP fami-
lies individually is extremely informative, but comparisons among 
the three families can be even more powerful. Human GAPs show 
very similar duplication patterns to the ARFs. Class I ARFs gave rise 
to ARFs 1-3, while class II ARFs gave rise to ARF4 and 5 (Manolea 
et al., 2010) (Figure 4B). The ARF GAPs show the same breakdown 
of two (ADAP, AGFG, GIT, SMAP) or three (ARFGAP, ACAP, AGAP, 
ARAP, ASAP) paralogues within these subfamilies (Schlacht et al., 
2013). This is a correlative observation, but raises testable models 
of coordinated activity of these proteins for which the substrate 
FIGURE 4: Evolution of the ARF family and its regulators. (A) The timing of the emergence of the relevant protein 
subfamilies is shown mapped on a simplified tree of eukaryotes. The polygons, circles, and squares denote the latest 
point by which the ARF GTPases, GAPs, and GEFs must have evolved, respectively, with the names of the subfamilies 
given to the right. The names of the eukaryotic supergroups are in italics, while the relevant “reconstructed ancestor” 
discussed in the text are in bold and noted by a dashed line. (B) Overlay of ARF1-5 evolution with that of the nine ARF 
GAP subfamilies that possess multiple paralogues. ARF evolution is depicted in black and Arf GAP in gray, with 
duplications at the base of Holozoa and Vertebrata. Relevant evolutionary transitions are illustrated by dashed lines.
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specificity and biological functions are poorly and incompletely un-
derstood. Whether the expansions in the GEFs reflect a coevolu-
tionary or functional relationship with the ARFs and GAPs is an open 
but exciting question. Interestingly, during the progressive expan-
sion of the ARFs and their regulatory machinery from the LECA to 
humans, some protein families have resisted expansion. There is 
only a single GBF1 (but two orthologues, Gea1 and Gea2, in yeast) 
and a single ArfGAP1, both of which act in the early secretory path-
way, suggesting a selective constraint on the plasticity of this path-
way, as compared with the late secretory and endocytic systems. 
Similarly, there is a single ARL2 that acts at multiple sites in distinct 
pathways but has resisted segregating those functions via duplica-
tion with paralogues having distinct localization and actions (Sharer 
and Kahn, 1999; Bowzard et al., 2005; Zhou et al., 2006; Newman 
et al., 2014). Evolutionary cell biology of cofunctioning families of 
proteins can reveal unexpected aspects of diverse organelle func-
tions (for examples, see Dacks and Robinson, 2017) and provide 
crossover insights into possible mechanisms of action and regula-
tory networks for each family. While the ARF family is typically de-
scribed as being one of four large families within the RAS superfam-
ily, the evolutionary analysis (Klinger et al., 2016), together with the 
unique and unifying structural mechanism employed by ARFs 
(Pasqualato et al., 2002; see also earlier discussion), argue that ARF 
GTPases form their own superfamily.
ARF GTPASES/GEFS/GAPS IN CANCER 
AND OTHER DISEASES
As for most small GTPases, ARFs (and their GEFs and GAPs) have 
been associated with human diseases, and many more roles in pa-
thologies continue to be discovered. A number of GTPases in the 
RAS superfamily have strong links to cancers, with RAS being the 
most commonly found mutated oncogene in human cancers and a 
RAS GAP, NF1, prominently altered in neurofibromatosis 
(Downward, 2003). We asked whether such links might be found 
within the human ARF families described herein. Interrogation of 
available next-generation sequencing data in the Cancer Genome 
Atlas (via http://cbioportal.com) reveals that ARF signaling is al-
tered in cancer (albeit less commonly than is RAS or RHO signal-
ing). Importantly, the mechanisms by which ARF GTPase/GEF/GAP 
signaling is genetically altered in cancers differs markedly from 
those seen in RAS and RHO families. RAS signaling is most com-
monly altered by missense mutation or amplification of the 
GTPases, deletion of RAS GAPs, and/or mutation of RAS effectors 
(Downward, 2003). Similarly, RHO signaling is most often altered 
by missense mutation or amplification of the GTPase, overexpres-
sion of GEFs, loss of GAPs, alterations in posttranslational modifi-
cations, and/or alternative splicing (Porter et al., 2016). In contrast, 
missense mutations that render ARF GAPs inactive are largely not 
observed, and the most common genetic alterations observed are 
amplification events, particularly of the GTPases ARF4 and ARL14 
and the ARF GAPs AGAP2 and ASAP1. ARF4 is commonly ampli-
fied in prostate cancer (20%) and is an important regulator of 
breast cancer cell migration (Jang et al., 2012). ARL14 has yet to 
be studied in the lab, but its high amplification rate in squamous 
cell lung cancer (23%), esophageal cancer (13%), and ovarian can-
cer (11%) merits further investigation. AGAP2 is often coamplified 
with CDK4 and promotes cancer cell survival, migration, and inva-
sion in glioblastoma models (Qi et al., 2017). ASAP1 expression 
correlates with metastatic potential in uveal melanoma, colon 
cancer, prostate cancer, and laryngeal squamous cell carcinoma 
(Ehlers et al., 2005; Muller et al., 2010; Li et al., 2014) and is associ-
ated with increased motility and invasiveness of uveal melanoma 
and breast cancer cells (Ehlers et al., 2005; Onodera et al., 2005). 
Furthermore, AGAP2 and ASAP1 amplification is associated with 
decreased overall and progression-free survival (Ehlers et al., 
2005). In addition, a number of reports implicate ARF4 (Jang et al., 
2012) and ARF6 (Hashimoto et al., 2004; Hongu et al., 2015; Li 
et al., 2017) in cancer cell migration, invasion, and metastasis. 
However, the molecular mechanisms through which the changes in 
ARF GTPases and their GAPs elicit pathology remain to be de-
fined. In addition to these amplification events, genomic deletions 
of at least one GTPase are observed. ARL11 (aka ADP-ribosylation 
factor-like tumor suppressor gene 1 [ARLTS1]), is commonly de-
leted in prostate cancer and sarcoma, and the expression of this 
gene in lung cancer is down-regulated due to promoter hyper-
methylation (Yendamuri et al., 2008). Likewise, the ARF GEF 
BRAG2 has been implicated in breast cancer and uveal melanoma 
(Morishige et al., 2008; Yoo et al., 2016).
Mutations in ARF GEFs have been identified as causes of human 
neurological disease. For example, a large number of mutations in 
BRAG1/IQSec2 have been identified and implicated in nonsyn-
dromic X-linked intellectual disability (Mignot et al., 2018), a subset 
of which occur within either the IQ motif or the Sec7d. These muta-
tions alter the trafficking of AMPA receptors in hippocampal neu-
rons, suggesting a molecular basis for the deficits in learning and 
memory associated with this disease. Schwann cell–specific deletion 
of BIG1 prevents myelination (Miyamoto et al., 2018), while muta-
tions in BIG2 cause periventricular heterotopia with microcephaly 
(Sheen et al., 2004; Lu et al., 2006; Grzmil et al., 2010). In both 
cases, we lack an understanding of the underlying mechanisms 
causing the GEF dysfunction.
TISSUE-SPECIFIC FUNCTIONS OF ARF 
GTPASES/GEFS/GAPS
There is growing evidence that at least some of these GTPases/
GEFs/GAPs (especially those arising late in evolution) show differ-
ential tissue expression patterns and act in a tissue-specific manner 
or are expressed and function during specific stages of develop-
ment. This is evident from studies in which specific GTPases have 
been mutated/deleted in mice (either total or tissue-specific knock-
out) and cause a variety of phenotypes (Table 4) (Mueller et al., 
2002; Schurmann et al., 2002; Schrick et al., 2006; Suzuki et al., 
2006; Caspary et al., 2007; Zahn et al., 2008; Hesse et al., 2010, 
2012; Hommel et al., 2010; Zhang et al., 2011; Jaschke et al., 2012; 
Akiyama et al., 2014; Hayakawa et al., 2014; Hongu et al., 2015; 
Hanke-Gogokhia et al., 2016, 2017; Huang et al., 2016; Li et al., 
2016; Lin et al., 2017; Bay et al., 2018; Dilan et al., 2018; Pearring 
et al., 2017; Rodiger et al., 2018). As might be expected for ancient 
and highly conserved proteins, several GTPases are essential, and 
their deletion results in embryonic lethality. However, the use of 
tissue-specific deletions provides a wealth of new information and 
highlights the importance of these proteins in cells, tissues, and 
whole organisms, as exemplified by deletions of ARF6 in endothe-
lial and neuronal cells as well as in platelets and podocytes and of 
the essential gene ARFRP1 in liver, adipocytes, or intestine (Table 4). 
Tissue-specific expression of designer mutations in GTPases/GEFs/
GAPs is another approach yielding novel insights (e.g., expression 
of the dominant active [Q70L]ARL2 in photoreceptor cells; Wright 
et al., 2018). There are also large efforts underway to systematically 
knock out each mouse gene, and these will add both key reagents 
and important information on the biology of the three families of 
proteins discussed herein. We did not include such data, but they 
can be found at the following sites: National Institutes of Health 
(NIH) Knockout Mouse Project (www.komp.org), Mouse Genome 
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Informatics (www.informatics.jax.org), and International Mouse Phe-
notyping Consortium (www.mousephenotype.org).
In addition, many ARF GTPase/GEF/GAP genes give rise to mul-
tiple splice isoforms, yet we know little or nothing about how the ex-
pression of such isoforms is regulated in different tissues, whether the 
isoforms have distinct cellular localizations, perform distinct actions, 
or are regulated through different mechanisms. For example, Cytohe-
sin 1 isoforms differing by the inclusion of a three-nucleotide glycine-
coding microexon in the PH domain display differential affinity for 
PI(4,5)P2 and PI(3,4,5)P3 and localize either to the PM (triglycine iso-
form) or to the leading edge (diglycine isoform) (Ratcliffe et al., 2018). 
Whether they perform different functions at those sites is unknown.
KEY QUESTIONS AND CHALLENGES
We reviewed key facets of current knowledge of ARF GTPases and 
their regulatory GEFs and GAPs. Here, we highlight what we con-
sider the most glaring deficiencies that, if addressed experimentally, 
will advance our understanding of the underlying mechanisms and 
regulation of a broad array of essential cell processes.
1. Functionalities of ARF family GTPases in cells: We are largely ig-
norant of how many different functions a single GTPase can per-
form in a cell, which GTPases support which cellular functions, 
and the extent to which functional redundancy between different 
GTPases occurs. In some cases, these functions may be very sim-
ilar (e.g., ARF1 regulating multiple steps of membrane traffick-
ing), while in others they may be distinct (e.g., ARL2 acting from 
the intermembrane space to regulate mitochondrial fusion and 
from the cytosol to regulate αβ-tubulin assembly). When a single 
GTPase performs multiple functions at distinct intracellular sites, 
how is its distribution regulated, and how are the distinct func-
tions coordinated to achieve integrated cellular homeostasis?
2. What subset of ARFs, GEFs, and GAPs is used in a given cellular 
response? It is well accepted that, if a regulatory GTPase is in-
volved in a specific pathway, it will need an upstream GEF and a 
downstream GAP/effector to serve that regulatory role. In vitro 
studies using purified components reconstituted on membranes 
provide a powerful means to decipher complex regulatory prop-
erties at the molecular level, determine affinities and specifici-
ties, and generate testable hypotheses to interrogate these 
mechanisms in the cell. However, in vitro conditions are poor 
mimetics of those in a cell, and it is challenging to identify how 
such mechanisms are mobilized, altered, or combined by the cell 
to generate a specific response.
3. ARF/GEF/GAP effectors/interactomes: We are largely ignorant 
of the proteins that bind to each GTPase/GEF/GAP and how 
such interactions influence their activity and/or downstream 
events. Do the effectors/interactomes differ depending on loca-
tion, and what defines the order, hierarchy, and cooperativity of 
such interactions? For example, do GEFs participate in the se-
lection of effectors, that is, do GEFs both activate ARFs and bind 
ARF effectors/GAPs to promote the specificity of the down-
stream event, perhaps serving as a scaffold, as shown for GBF1 
binding the γ-COP component of the coatomer (Deng et al., 
2009)? Our fragmentary knowledge of ARF family effectors and 
the downstream actions they perform is largely due to three 
technical difficulties. First, many GTPase-GAP/effector interac-
tions occur within the constricted diffusion of effectors “solid 
phased” on the membrane surface and have relatively weak af-
finities in solution, making many common techniques of interac-
tor identification (e.g., coimmunoprecipitation, affinity chroma-
tography, or copurification) of limited utility. Second, ARFs often 
work in concert with phospholipids in so-called coincidence de-
tection mechanisms, in which the interactions may require a par-
ticular lipid composition or membrane curvature. One example 
of this is the recruitment of the AP-1 clathrin adaptor complex to 
endosomal membranes, which requires its simultaneous binding 
to both ARF1 and the phosphoinositide PI(4)P (Ren et al., 2013). 
Identification of new ARF effectors may therefore require affinity 
isolation approaches that incorporate lipids. Just such an ap-
proach recently identified a lipid-dependent interaction be-
tween ARF1 and the actin regulatory WAVE complex (Koronakis 
et al., 2011). Third, most of these protein are cytosolic and may 
only transiently and incompletely associate with membranes to 
perform their key regulatory function(s), making it common for 
databases designed to catalogue localizations of proteins in 
cells or interactomes to miss important sites of action (e.g., 
compare our Figure 1 with data in the Human Protein Atlas: 
www.proteinatlas.org).
4. Posttranslational modifications: ARF GTPases/GEFs/GAPs are 
subject to posttranslational modifications that include phosphor-
ylation and ubiquitination. These modification are transient and 
are likely to play important roles in localization, activation, selec-
tion of binding partners, and biological outputs. However, very 
few studies have analyzed the consequences of posttranslational 
modifications on protein function(s) or identified the responsible 
kinase or other modifiers. We also are ignorant of how the func-
tional or metabolic status of a cell influences phosphorylation of 
specific proteins to evoke the appropriate functional response.
5. Identification of ARL GEFs and GAPs: This review focuses on the 
ARF GEFs and GAPs, largely because so little is known about the 
identity of ARL GEFs, GAPs, or effectors. Although ARLs com-
prise the largest group of the ARF family, we know the least 
about them and their regulators/interactors. We believe that the 
identification and characterization of each new GAP/GEF will 
provide important new insights into the regulation of essential 
cell processes. The finding that ELMODs, purified from mam-
malian tissues based on their GAP activity toward ARL2, also act 
on ARFs, showcases our ignorance of important and unexpected 
means of regulating ARFs as well as ARLs. Such studies increase 
the complexity and the challenges in sorting out specificities and 
pathways, but without such missing information, we risk funda-
mentally misinterpreting a lot of what we think we know about 
signaling by the ARF family.
SUMMARY
Surprisingly, despite decades of accumulated knowledge on ARF 
GTPases and their GEFs and GAPs, including an atomic understand-
ing of the GDP/GTP exchange and GTP hydrolysis reactions, we re-
main ignorant of fundamental and key aspects of their action and 
regulation. Defining the answers posed here for even a single pro-
tein is a daunting task for any investigator. Yet, we argue that study-
ing the entire ARF family of GTPases together and in concert with 
the families of their GEFs and GAPs will provide substantially more 
information and is critical to our understanding of 1) sources of spec-
ificity and functional redundancies, 2) complexities resulting from 
one protein acting at multiple sites, 3) enigmas of coordination be-
tween multiple GTPases to perform a single function, 4) the inter-
connections between ARF signaling and other cellular functions, and 
5) how the actions of the GTPases/GEFs/GAPs are integrated with 
cellular physiology and/or contribute to pathology when gone awry. 
No one laboratory can hope to make more than a small dent in the 
black box before us. Thus, we hope that this review might serve as 
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an argument in support of more collaborative efforts to address this 
large, complex, but vitally important field of ARF signaling.
ACKNOWLEDGMENTS
We regret the many omissions of citations of outstanding work in the 
field that could not be cited or discussed in greater detail due to 
space limitations. This work was supported by grants from the NIH 
(R35GM122568 to R.A.K., R01DK093729 to L.C.S., R01GM127361 
to J.E.C., R01GM122802 to E.S., R01GM056324 to D.G.L.), the 
National Science Foundation (MCB-1615607 to E.S.), the German 
Research Foundation DFG (SFB 958 to I.W. and A.S.), the National 
Health Research Institutes (NHRI) in Taiwan (NHRI-EX106-10601B1 to 
F.-J.S.L.), the NIH Intramural Program (project BC 007365 to P.A.R. 
and BC011805 to M.E.Y.), Alex’s Lemonade Stand Foundation Young 
Investigator Award (M.E.Y.), the Institut National du Cancer (INCa, 
grant number 2014-160 to J.C.), and the Fondation pour la Recher-
che Médicale (FRM, grant number DEQ20150331694 to J.C.). J.B.D. 
is the Canada Research Chair (Tier II) in Evolutionary Cell Biology.
REFERENCES
Ahmadian MR, Stege P, Scheffzek K, Wittinghofer A (1997). Confirmation 
of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis 
reaction of Ras. Nat Struct Biol 4, 686–689.
Aizel K, Biou V, Navaza J, Duarte LV, Campanacci V, Cherfils J, Zeghouf M 
(2013). Integrated conformational and lipid-sensing regulation of endo-
somal ArfGEF BRAG2. PLoS Biol 11, e1001652.
Akiyama M, Hasegawa H, Hongu T, Frohman MA, Harada A, Sakagami H, 
Kanaho Y (2014). Trans-regulation of oligodendrocyte myelination by 
neurons through small GTPase Arf6-regulated secretion of fibroblast 
growth factor-2. Nat Commun 5, 4744.
Alkanderi S, Molinari E, Shaheen R, Elmaghloob Y, Stephen LA, Sammut V, 
Ramsbottom SA, Srivastava S, Cairns G, Edwards N, et al. (2018). ARL3 
mutations cause Joubert syndrome by disrupting ciliary protein compo-
sition. Am J Hum Genet 103, 612–620.
Altan-Bonnet N, Phair RD, Polishchuk RS, Weigert R, Lippincott-Schwartz J 
(2003). A role for Arf1 in mitotic Golgi disassembly, chromosome segre-
gation, and cytokinesis. Proc Natl Acad Sci USA 100, 13314–13319.
Alvarez C, Garcia-Mata R, Brandon E, Sztul E (2003). COPI recruitment 
is modulated by a Rab1b-dependent mechanism. Mol Biol Cell 14, 
2116–2127.
Amin E, Jaiswal M, Derewenda U, Reis K, Nouri K, Koessmeier KT, 
Aspenstrom P, Somlyo AV, Dvorsky R, Ahmadian MR (2016). Deciphering 
the molecular and functional basis of RHOGAP family proteins: a sys-
tematic approach toward selective inactivation of RHO family proteins. J 
Biol Chem 291, 20353–20371.
Amor JC, Harrison DH, Kahn RA, Ringe D (1994). Structure of the human 
ADP-ribosylation factor 1 complexed with GDP. Nature 372, 704–708.
Antonny B, Beraud-Dufour S, Chardin P, Chabre M (1997). N-terminal hy-
drophobic residues of the G-protein ADP-ribosylation factor-1 insert into 
membrane phospholipids upon GDP to GTP exchange. Biochemistry 
36, 4675–4684.
Arimoto K, Funami K, Saeki Y, Tanaka K, Okawa K, Takeuchi O, Akira S, 
Murakami Y, Shimotohno K (2010). Polyubiquitin conjugation to NEMO 
by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc 
Natl Acad Sci USA 107, 15856–15861.
Attar MA, Santy LC (2013). The scaffolding protein GRASP/Tamalin directly 
binds to Dock180 as well as to cytohesins facilitating GTPase crosstalk in 
epithelial cell migration. BMC Cell Biol 14, 9.
Bach AS, Enjalbert S, Comunale F, Bodin S, Vitale N, Charrasse S, Gauthier-
Rouviere C (2010). ADP-ribosylation factor 6 regulates mammalian 
myoblast fusion through phospholipase D1 and phosphatidylinositol 
4,5-bisphosphate signaling pathways. Mol Biol Cell 21, 2412–2424.
Bai M, Gad H, Turacchio G, Cocucci E, Yang JS, Li J, Beznoussenko GV, 
Nie ZZ, Luo RB, Fu LW, et al. (2011). ARFGAP1 promotes AP-2-depen-
dent endocytosis. Nat Cell Biol 13, 559–U144.
Barrett T, Xiao B, Dodson EJ, Dodson G, Ludbrook SB, Nurmahomed K, 
Gamblin SJ, Musacchio A, Smerdon SJ, Eccleston JF (1997). The structure 
of the GTPase-activating domain from p50rhoGAP. Nature 385, 458–461.
Bay SN, Long AB, Caspary T (2018). Disruption of the ciliary GTPase Arl13b 
suppresses Sonic hedgehog overactivation and inhibits medulloblas-
toma formation. Proc Natl Acad Sci USA 115, 1570–1575.
Beraud-Dufour S, Robineau S, Chardin P, Paris S, Chabre M, Cherfils J, 
Antonny B (1998). A glutamic finger in the guanine nucleotide exchange 
factor ARNO displaces Mg2+ and the beta-phosphate to destabilize 
GDP on ARF1. EMBO J 17, 3651–3659.
Bigay J, Casella JF, Drin G, Mesmin B, Antonny B (2005). ArfGAP1 responds 
to membrane curvature through the folding of a lipid packing sensor 
motif. EMBO J 24, 2244–2253.
Boman AL, Zhang C, Zhu X, Kahn RA (2000). A family of ADP-ribosylation 
factor effectors that can alter membrane transport through the trans-
Golgi. Mol Biol Cell 11, 1241–1255.
Boulakirba S, Macia E, Partisani M, Lacas-Gervais S, Brau F, Luton F, Franco 
M (2014). Arf6 exchange factor EFA6 and endophilin directly interact at 
the plasma membrane to control clathrin-mediated endocytosis. Proc 
Natl Acad Sci USA 111, 9473–9478.
Bouvet S, Golinelli-Cohen MP, Contremoulins V, Jackson CL (2013). Target-
ing of the Arf-GEF GBF1 to lipid droplets and Golgi membranes. J Cell 
Sci 126, 4794–4805.
Bowzard JB, Cheng D, Peng J, Kahn RA (2007). ELMOD2 is an Arl2 
GTPase-activating protein that also acts on Arfs. J Biol Chem 282, 
17568–17580.
Bowzard JB, Sharer JD, Kahn RA (2005). Assays used in the analysis of Arl2 
and its binding partners. Methods Enzymol 404, 453–467.
Brown HA, Gutowski S, Moomaw CR, Slaughter C, Sternweis PC (1993). 
ADP-ribosylation factor, a small GTP-dependent regulatory pro-
tein, stimulates phospholipase D activity [see comments]. Cell 75, 
1137–1144.
Bui QT, Golinelli-Cohen MP, Jackson CL (2009). Large Arf1 guanine 
nucleotide exchange factors: evolution, domain structure, and roles in 
membrane trafficking and human disease. Mol Genet Genomics 282, 
329–350.
Busby T, Meissner JM, Styers ML, Bhatt J, Kaushik A, Hjelmeland AB, Sztul 
E (2017). The Arf activator GBF1 localizes to plasma membrane sites 
involved in cell adhesion and motility. Cell Logist 7, e1308900.
Campa F, Yoon HY, Ha VL, Szentpetery Z, Balla T, Randazzo PA (2009). A 
PH Domain in the Arf GTPase-activating protein (GAP) ARAP1 binds 
phosphatidylinositiol 3,4,5-trisphosphate and regulates Arf GAP activity 
independently of recruitment to the plasma membranes. J Biol Chem 
284, 28069–28083.
Casalou C, Faustino A, Barral DC (2016). Arf proteins in cancer cell migra-
tion. Small GTPases 7, 270–282.
Casalou C, Seixas C, Portelinha A, Pintado P, Barros M, Ramalho JS, Lopes 
SS, Barral DC (2014). Arl13b and the non-muscle myosin heavy chain IIA 
are required for circular dorsal ruffle formation and cell migration. J Cell 
Sci 127, 2709–2722.
Casanova JE (2007). Regulation of Arf activation: the Sec7 family of guanine 
nucleotide exchange factors. Traffic 8, 1476–1485.
Caspary T, Larkins CE, Anderson KV (2007). The graded response to Sonic 
Hedgehog depends on cilia architecture. Dev Cell 12, 767–778.
Caumont AS, Vitale N, Gensse M, Galas MC, Casanova JE, Bader MF 
(2000). Identification of a plasma membrane-associated guanine nucleo-
tide exchange factor for ARF6 in chromaffin cells. Possible role in the 
regulated exocytotic pathway. J Biol Chem 275, 15637–15644.
Charych EI, Yu W, Miralles CP, Serwanski DR, Li X, Rubio M, De Blas AL 
(2004). The brefeldin A-inhibited GDP/GTP exchange factor 2, a protein 
involved in vesicular trafficking, interacts with the beta subunits of the 
GABA receptors. J Neurochem 90, 173–189.
Chen J, Wu X, Yao L, Yan L, Zhang L, Qiu J, Liu X, Jia S, Meng A (2017). 
Impairment of cargo transportation caused by gbf1 mutation disrupts 
vascular integrity and causes hemorrhage in zebrafish embryos. J Biol 
Chem 292, 2315–2327.
Chen PW, Jian X, Heissler SM, Le K, Luo R, Jenkins LM, Nagy A, Moss J, 
Sellers JR, Randazzo PA (2016). The Arf GTPase-activating protein, 
ASAP1, binds nonmuscle myosin 2A to control remodeling of the acto-
myosin network. J Biol Chem, 291, 7517–7526.
Chen PW, Jian XY, Yoon HY, Randazzo PA (2013). ARAP2 signals through 
Arf6 and Rac1 to control focal adhesion morphology. J Biol Chem 288, 
5849–5860.
Chen P-W, Luo R, Jian X, Randazzo PA (2014). The Arf6 GTPase-activating 
proteins ARAP2 and ACAP1 define distinct endosomal compartments 
that regulate integrin α5β1 traffic. J Biol Chem 289, 30237–30248.
Cherfils J (2014). Arf GTPases and their effectors: assembling multivalent 
membrane-binding platforms. Curr Opin Struct Biol 29, 67–76.
Cherfils J, Chardin P (1999). GEFs: structural basis for their activation of 
small GTP-binding proteins. Trends Biochem Sci 24, 306–311.
Cherfils J, Zeghouf M (2013). Regulation of small GTPases by GEFs, GAPs, 
and GDIs. Physiol Rev 93, 269–309.
1266 | E. Sztul et al. Molecular Biology of the Cell
Chiang AP, Nishimura D, Searby C, Elbedour K, Carmi R, Ferguson AL, 
Secrist J, Braun T, Casavant T, Stone EM, et al. (2004). Comparative 
genomic analysis identifies an ADP-ribosylation factor-like gene as the 
cause of Bardet-Biedl syndrome (BBS3). Am J Hum Genet 75, 475–484.
Chiang TS, Wu HF, Lee FS (2017). ADP-ribosylation factor-like 4C binding to 
filamin-A modulates filopodium formation and cell migration. Mol Biol 
Cell 28, 3013–3028.
Christis C, Munro S (2012). The small G protein Arl1 directs the trans-Golgi-
specific targeting of the Arf1 exchange factors BIG1 and BIG2. J Cell 
Biol 196, 327–335.
Cockcroft S, Thomas GM, Fensome A, Geny B, Cunningham E, Gout I, Hiles 
I, Totty NF, Truong O, Hsuan JJ (1994). Phospholipase D: a downstream 
effector of ARF in granulocytes. Science 263, 523–526.
Cohen LA, Honda A, Varnai P, Brown FD, Balla T, Donaldson JG (2007). 
Active Arf6 recruits ARNO/Cytohesin GEFs to the PM by binding their 
PH domains. Mol Biol Cell 18, 2244–2253.
Cronin TC, DiNitto JP, Czech MP, Lambright DG (2004). Structural determi-
nants of phosphoinositide selectivity in splice variants of Grp1 family PH 
domains. EMBO J 23, 3711–3720.
Cruz-Garcia D, Ortega-Bellido M, Scarpa M, Villeneuve J, Jovic M, Porzner 
M, Balla T, Seufferlein T, Malhotra V (2013). Recruitment of arfaptins to 
the trans-Golgi network by PI(4)P and their involvement in cargo export. 
EMBO J 32, 1717–1729.
Cukierman E, Huber I, Rotman M, Cassel D (1995). The ARF1 GTPase acti-
vating protein: zinc finger motif and Golgi complex localization. Science 
270, 1999–2002.
Dacks JB, Robinson MS (2017). Outerwear through the ages: evolutionary 
cell biology of vesicle coats. Curr Opin Cell Biol 47, 108–116.
Decressac S, Franco M, Bendahhou S, Warth R, Knauer S, Barhanin J, 
Lazdunski M, Lesage F (2004). ARF6-dependent interaction of the 
TWIK1 K+ channel with EFA6, a GDP/GTP exchange factor for ARF6. 
EMBO Rep 5, 1171–1175.
Dell’Angelica EC, Puertollano R, Mullins C, Aguilar RC, Vargas JD, Hartnell 
LM, Bonifacino JS (2000). GGAs: a family of ADP ribosylation factor-
binding proteins related to adaptors and associated with the Golgi 
complex. J Cell Biol 149, 81–94.
Deng Y, Golinelli-Cohen MP, Smirnova E, Jackson CL (2009). A COPI coat 
subunit interacts directly with an early-Golgi localized Arf exchange fac-
tor. EMBO Rep 10, 58–64.
Derby MC, van Vliet C, Brown D, Luke MR, Lu L, Hong W, Stow JL, Gleeson 
PA (2004). Mammalian GRIP domain proteins differ in their membrane 
binding properties and are recruited to distinct domains of the TGN. 
J Cell Sci 117(Pt 24), 5865–5874.
Dilan TL, Moye AR, Salido EM, Saravanan T, Saravanan K, Goldberg AFX, 
Ramamurthy V (2018). ARL13B, a Joubert syndrome-associated protein, 
is critical for retinogenesis and elaboration of mouse photoreceptor 
outer segments. J Neurosci 39, 1347–1364.
DiNitto JP, Cronin TC, Lambright DG (2003). Membrane recognition and 
targeting by lipid-binding domains. Sci STKE 2003, re16.
DiNitto JP, Delprato A, Gabe Lee MT, Cronin TC, Huang S, Guilherme A, 
Czech MP, Lambright DG (2007). Structural basis and mechanism of au-
toregulation in 3-phosphoinositide-dependent Grp1 family Arf GTPase 
exchange factors. Mol Cell 28, 569–583.
Dodonova SO, Aderhold P, Kopp J, Ganeva I, Rohling S, Hagen WJH, 
Sinning I, Wieland F, Briggs JAG (2017). 9A structure of the COPI coat 
reveals that the Arf1 GTPase occupies two contrasting molecular envi-
ronments. Elife 6, eLife.26691.
Donaldson JG (2003). Multiple roles for Arf6: sorting, structuring, and sig-
naling at the plasma membrane. J Biol Chem 278, 41573–41576.
Donaldson JG, Jackson CL (2011). ARF family G proteins and their regula-
tors: roles in membrane transport, development and disease. Nat Rev 
Mol Cell Biol 12, 362–375.
Downward J (2003). Targeting RAS signalling pathways in cancer therapy. 
Nat Rev Cancer 3, 11–22.
Drake MT, Zhu Y, Kornfeld S (2000). The assembly of AP-3 adaptor complex-
containing clathrin-coated vesicles on synthetic liposomes. Mol Biol Cell 
11, 3723–3736.
D’Souza RS, Casanova JE (2016). The BRAG/IQSec family of Arf GEFs. Small 
GTPases 7, 257–264.
D’Souza RS, Semus R, Billings EA, Meyer CB, Conger K, Casanova JE 
(2014). Rab4 orchestrates a small GTPase cascade for recruitment of 
adaptor proteins to early endosomes. Curr Biol 24, 1187–1198.
D’Souza-Schorey C, Chavrier P (2006). ARF proteins: roles in membrane traf-
fic and beyond. Nat Rev Mol Cell Biol 7, 347–358.
Dunphy JL, Ye K, Casanova JE (2007). Nuclear functions of the Arf guanine 
nucleotide exchange factor BRAG2. Traffic 8, 661–672.
East MP, Bowzard JB, Dacks JB, Kahn RA (2012). ELMO domains, evolu-
tionary and functional characterization of a novel GTPase-activating 
protein (GAP) domain for Arf protein family GTPases. J Biol Chem 287, 
39538–39553.
East MP, Kahn RA (2011). Models for the functions of Arf GAPs. Semin Cell 
Dev Biol 22, 3–9.
Ehlers JP, Worley L, Onken MD, Harbour JW (2005). DDEF1 is located in 
an amplified region of chromosome 8q and is overexpressed in uveal 
melanoma. Clin Cancer Res 11, 3609–3613.
Eiseler T, Wille C, Koehler C, Illing A, Seufferlein T (2016). Protein Kinase D2 
assembles a multiprotein complex at the trans-Golgi network to regulate 
matrix metalloproteinase secretion. J Biol Chem 291, 462–477.
Elagabani MN, Brisevac D, Kintscher M, Pohle J, Kohr G, Schmitz D, Kornau 
HC (2016). Subunit-selective N-methyl-d-aspartate (NMDA) receptor 
signaling through Brefeldin A-resistant Arf guanine nucleotide exchange 
factors BRAG1 and BRAG2 during synapse maturation. J Biol Chem 
291, 9105–9118.
Ellong EN, Soni KG, Bui QT, Sougrat R, Golinelli-Cohen MP, Jackson CL 
(2011). Interaction between the triglyceride lipase ATGL and the Arf1 
activator GBF1. PLoS One 6, e21889.
Eme L, Sharpe SC, Brown MW, Roger AJ (2014). On the age of eukaryotes: 
evaluating evidence from fossils and molecular clocks. Cold Spring Harb 
Perspect Biol 6, a016139.
Francis JW, Goswami D, Novick SJ, Pascal BD, Weikum ER, Ortlund 
EA, Griffin PR, Kahn RA (2017a). Nucleotide binding to ARL2 in the 
TBCDARL2β-tubulin complex drives conformational changes in β-
tubulin. J Mol Biol 429, 3696–3716.
Francis JW, Newman LE, Cunningham LA, Kahn RA (2017b). A trimer 
consisting of the tubulin-specific chaperone D (TBCD), regulatory 
GTPase ARL2, and β-Tubulin is required for maintaining the microtubule 
network. J Biol Chem 292, 4336–4349.
Francis JW, Turn RE, Newman LE, Schiavon C, Kahn RA (2016). Higher order 
signaling: ARL2 as regulator of both mitochondrial fusion and micro-
tubule dynamics allows integration of 2 essential cell functions. Small 
GTPases 7, 188–196.
Franco M, Peters PJ, Boretto J, van Donselaar E, Neri A, D’Souza-Schorey 
C, Chavrier P (1999). EFA6, a sec7 domain-containing exchange factor 
for ARF6, coordinates membrane recycling and actin cytoskeleton orga-
nization. EMBO J 18, 1480–1491.
Frank SR, Adelstein MR, Hansen SH (2006). GIT2 represses Crk- and Rac1-
regulated cell spreading and Cdc42-mediated focal adhesion turnover. 
EMBO J 25, 1848–1859.
Frank SR, Hatfield JC, Casanova JE (1998). Remodeling of the actin 
cytoskeleton is coordinately regulated by protein kinase C and the ADP-
ribosylation factor nucleotide exchange factor ARNO. Mol Biol Cell 9, 
3133–3146.
Fuss B, Becker T, Zinke I, Hoch M (2006). The cytohesin Steppke is essential 
for insulin signalling in Drosophila. Nature 444, 945–948.
Gambardella L, Anderson KE, Jakus Z, Voigt S, Hawkins PT, Stephens L, 
Mocsai A, Vermeren S (2012). ARAP3 functions downstream of PI3K to 
regulate neutrophils. Eur J Clin Invest 42, 25–25.
Gambardella L, Anderson KE, Nussbaum C, Segonds-Pichon A, Margarido 
T, Norton L, Ludwig T, Sperandio M, Hawkins PT, Stephens L, et al. 
(2011). The GTPase-activating protein ARAP3 regulates chemotaxis and 
adhesion-dependent processes in neutrophils. Blood 118, 1087–1098.
Gehart H, Goginashvili A, Beck R, Morvan J, Erbs E, Formentini I, De Mat-
teis MA, Schwab Y, Wieland FT, Ricci R (2012). The BAR domain protein 
Arfaptin-1 controls secretory granule biogenesis at the trans-Golgi 
network. Dev Cell 23, 756–768.
Gilbert CE, Sztul E, Machamer CE (2018). Commonly used trafficking blocks 
disrupt ARF1 activation and the localization and function of specific 
Golgi proteins. Mol Biol Cell 29, 937–947.
Gillingham AK, Munro S (2007). The small G proteins of the Arf family and 
their regulators. Annu Rev Cell Dev Biol 23, 579–611.
Godi A, Di Campli A, Konstantakopoulos A, Di Tullio G, Alessi DR, Kular GS, 
Daniele T, Marra P, Lucocq JM, De Matteis MA (2004). FAPPs control 
Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. 
Nat Cell Biol 6, 393–404.
Goldberg J (1998). Structural basis for activation of ARF GTPase: mecha-
nisms of guanine nucleotide exchange and GTP-myristoyl switching. 
Cell 95, 237–248.
Goldberg J (2000). Decoding of sorting signals by coatomer through a 
GTPase switch in the COPI coat complex. Cell 100, 671–679.
Gotthardt K, Lokaj M, Koerner C, Falk N, Giessl A, Wittinghofer A (2015). 
A G-protein activation cascade from Arl13B to Arl3 and implications for 
ciliary targeting of lipidated proteins. Elife 4, eLife.11859.
Volume 30 May 15, 2019 ARF GTPases: concepts and challenges | 1267 
Grzmil P, Enkhbaatar Z, Gundsambuu B, Oidovsambuu O, Yalcin S, Wolf S, 
Engel W, Neesen J (2010). Early embryonic lethality in gene trap mice 
with disruption of the Arfgef2 gene. Int J Dev Biol 54, 1259–1266.
Gupta GD, Swetha MG, Kumari S, Lakshminarayan R, Dey G, Mayor S 
(2009). Analysis of endocytic pathways in Drosophila cells reveals a con-
served role for GBF1 in internalization via GEECs. PLoS One 4, e6768.
Gustafson MA, Fromme JC (2017). Regulation of Arf activation occurs via 
distinct mechanisms at early and late Golgi compartments. Mol Biol Cell 
28, 3660–3671.
Ha VL, Luo RB, Nie ZZ, Randazzo PA (2008). Contribution of AZAP-type Arf 
GAPs to cancer cell migration and invasion. Adv Canc Res, 101, 1–28.
Hafner M, Schmitz A, Grune I, Srivatsan SG, Paul B, Kolanus W, Quast T, 
Kremmer E, Bauer I, Famulok M (2006). Inhibition of cytohesins by 
SecinH3 leads to hepatic insulin resistance. Nature 444, 941–944.
Hahn I, Fuss B, Peters A, Werner T, Sieberg A, Gosejacob D, Hoch M (2013). 
The Drosophila Arf GEF Steppke controls MAPK activation in EGFR 
signaling. J Cell Sci 126, 2470–2479.
Hanai A, Ohgi M, Yagi C, Ueda T, Shin H-W, Nakayama K (2016). Class I Arfs 
(Arf1 and Arf3) and Arf6 are localized to the Flemming body and play 
important roles in cytokinesis. J Biochem 159, 201–208.
Hanke-Gogokhia C, Frederick JM, Zhang H, Baehr W (2018). Binary function 
of ARL3-GTP revealed by gene knockouts. Adv Exp Med Biol 1074, 
317–325.
Hanke-Gogokhia C, Wu Z, Gerstner CD, Frederick JM, Zhang H, Baehr W 
(2016). Arf-like protein 3 (ARL3) regulates protein trafficking and cilio-
genesis in mouse photoreceptors. J Biol Chem 291, 7142–7155.
Hanke-Gogokhia C, Wu Z, Sharif A, Yazigi H, Frederick JM, Baehr W (2017). 
The guanine nucleotide exchange factor, Arf-like protein 13b, is essen-
tial for assembly of the mouse photoreceptor transition zone and outer 
segment. J Biol Chem 292, 21442–21456.
Hashimoto S, Onodera Y, Hashimoto A, Tanaka M, Hamaguchi M, Yamada 
A, Sabe H (2004). Requirement for Arf6 in breast cancer invasive activi-
ties. Proc Natl Acad Sci USA 101, 6647–6652.
Hayakawa N, Ogoh H, Sumiyoshi M, Matsui Y, Nishikawa S, Miyamoto K, 
Maede Y, Kiyonari H, Suzuki M, Watanabe T (2014). The ADP-ribosyl-
ation factor 1 gene is indispensable for mouse embryonic development 
after implantation. Biochem Biophys Res Commun 453, 748–753.
Hesse D, Hommel A, Jaschke A, Moser M, Bernhardt U, Zahn C, Kluge 
R, Wittschen P, Gruber AD, Al-Hasani H, et al. (2010). Altered GLUT4 
trafficking in adipocytes in the absence of the GTPase Arfrp1. Biochem 
Biophys Res Commun 394, 896–903.
Hesse D, Jaschke A, Kanzleiter T, Witte N, Augustin R, Hommel A, Puschel 
GP, Petzke KJ, Joost HG, Schupp M, et al. (2012). GTPase ARFRP1 is 
essential for normal hepatic glycogen storage and insulin-like growth 
factor 1 secretion. Mol Cell Biol 32, 4363–4374.
Hiester KG, Santy LC (2013). The cytohesin coiled-coil domain interacts with 
threonine 276 to control membrane association. PLoS One 8, e82084.
Higginbotham H, Eom TY, Mariani LE, Bachleda A, Hirt J, Gukassyan V, 
Cusack CL, Lai C, Caspary T, Anton ES (2012). Arl13b in primary cilia 
regulates the migration and placement of interneurons in the develop-
ing cerebral cortex. Dev Cell 23, 925–938.
Hill K, Li Y, Bennett M, McKay M, Zhu X, Shern J, Torre E, Lah JJ, Levey AI, 
Kahn RA (2003). Munc18 interacting proteins: ADP-ribosylation factor-
dependent coat proteins that regulate the traffic of beta-Alzheimer’s 
precursor protein. J Biol Chem 278, 36032–36040.
Hirst J, Bright NA, Rous B, Robinson MS (1999). Characterization of a fourth 
adaptor-related protein complex. Mol Biol Cell 10, 2787–2802.
Hoefen RJ, Berk BC (2006). The multifunctional GIT family of proteins. J Cell 
Sci 119, 1469–1475.
Hofmann I, Thompson A, Sanderson CM, Munro S (2007). The Arl4 family of 
small G proteins can recruit the cytohesin Arf6 exchange factors to the 
plasma membrane. Curr Biol 17, 711–716.
Hommel A, Hesse D, Volker W, Jaschke A, Moser M, Engel T, Bluher M, 
Zahn C, Chadt A, Ruschke K, et al. (2010). The ARF-like GTPase ARFRP1 
is essential for lipid droplet growth and is involved in the regulation of 
lipolysis. Mol Cell Biol 30, 1231–1242.
Honda A, Nogami M, Yokozeki T, Yamazaki M, Nakamura H, Watanabe 
H, Kawamoto K, Nakayama K, Morris AJ, Frohman MA, et al. (1999). 
Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effec-
tor of the small G protein ARF6 in membrane ruffle formation. Cell 99, 
521–532.
Hongu T, Funakoshi Y, Fukuhara S, Suzuki T, Sakimoto S, Takakura N, Ema 
M, Takahashi S, Itoh S, Kato M, et al. (2015). Arf6 regulates tumour an-
giogenesis and growth through HGF-induced endothelial beta1 integrin 
recycling. Nat Commun 6, 7925.
Huang Y, Joshi S, Xiang B, Kanaho Y, Li Z, Bouchard BA, Moncman CL, 
Whiteheart SW (2016). Arf6 controls platelet spreading and clot retrac-
tion via integrin αIIbβ3 trafficking. Blood 127, 1459–1467.
Inaba Y, Tian QB, Okano A, Zhang JP, Sakagami H, Miyazawa S, Li W, 
Komiyama A, Inokuchi K, Kondo H, et al. (2004). Brain-specific potential 
guanine nucleotide exchange factor for Arf, synArfGEF (Po), is localized 
to postsynaptic density. J Neurochem 89, 1347–1357.
Inoue H, Randazzo PA (2007). Arf GAPs and their interacting proteins. Traffic 
8, 1465–1475.
Ishizaki R, Shin HW, Mitsuhashi H, Nakayama K (2008). Redundant roles of 
BIG2 and BIG1, guanine-nucleotide exchange factors for ADP-ribosyl-
ation factors in membrane traffic between the trans-Golgi network and 
endosomes. Mol Biol Cell 19, 2650–2660.
Ismail SA, Chen YX, Miertzschke M, Vetter IR, Koerner C, Wittinghofer A 
(2012). Structural basis for Arl3-specific release of myristoylated ciliary 
cargo from UNC119. EMBO J 31, 4085–4094.
Ismail SA, Chen YX, Rusinova A, Chandra A, Bierbaum M, Gremer L, Triola 
G, Waldmann H, Bastiaens PI, Wittinghofer A (2011). Arl2-GTP and Arl3-
GTP regulate a GDI-like transport system for farnesylated cargo. Nat 
Chem Biol 7, 942–949.
Ismail SA, Vetter IR, Sot B, Wittinghofer A (2010). The structure of an Arf-Arf-
GAP complex reveals a Ca2+ regulatory mechanism. Cell 141, 812–821.
Ivanova AA, Caspary T, Seyfried NT, Duong DM, West AB, Liu Z, Kahn RA 
(2017). Biochemical characterization of purified mammalian ARL13B pro-
tein indicates that it is an atypical GTPase and ARL3 guanine nucleotide 
exchange factor (GEF). J Biol Chem 292, 11091–11108.
Ivanova AA, East MP, Yi SL, Kahn RA (2014). Characterization of recom-
binant ELMOD (cell engulfment and motility domain) proteins as 
GTPase-activating proteins (GAPs) for ARF family GTPases. J Biol 
Chem 289, 11111–11121.
Jackson CL, Bouvet S (2014). Arfs at a glance. J Cell Sci 127, 4103–4109.
Jackson CL, Casanova JE (2000). Turning on ARF: the Sec7 family of 
guanine-nucleotide-exchange factors. Trends Cell Biol 10, 60–67.
Jang SY, Jang SW, Ko J (2012). Regulation of ADP-ribosylation factor 4 
expression by small leucine zipper protein and involvement in breast 
cancer cell migration. Cancer Lett 314, 185–197.
Jaschke A, Chung B, Hesse D, Kluge R, Zahn C, Moser M, Petzke KJ, 
Brigelius-Flohe R, Puchkov D, Koepsell H, et al. (2012). The GTPase 
ARFRP1 controls the lipidation of chylomicrons in the Golgi of the 
intestinal epithelium. Hum Mol Genet 21, 3128–3142.
Jian X, Cavenagh M, Gruschus JM, Randazzo PA, Kahn RA (2010). Modifica-
tions to the C-terminus of Arf1 alter cell functions and protein interac-
tions. Traffic 11, 732–742.
Jian X, Gruschus JM, Sztul E, Randazzo PA (2012). The pleckstrin homology 
(PH) domain of the Arf exchange factor Brag2 is an allosteric binding 
site. J Biol Chem 287, 24273–24283.
Jian X, Tang WK, Zhai P, Roy NS, Luo R, Gruschus JM, Yohe ME, Chen PW, 
Li Y, Byrd RA, et al. (2015). Molecular basis for cooperative binding 
of anionic phospholipids to the PH domain of the Arf GAP ASAP1. 
Structure, doi:10.1016/j.str.2015.08.008.
Jian XY, Brown P, Schuck P, Gruschus JM, Balbo A, Hinshaw JE, Randazzo 
PA (2009). Autoinhibition of Arf GTPase-activating protein activity by the 
BAR domain in ASAP1. J Biol Chem 284, 1652–1663.
Jin H, Nachury MV (2009). The BBSome. Curr Biol 19, R472–R473.
Jin H, White SR, Shida T, Schulz S, Aguiar M, Gygi SP, Bazan JF, Nachury MV 
(2010). The conserved Bardet-Biedl syndrome proteins assemble a coat 
that traffics membrane proteins to cilia. Cell 141, 1208–1219.
Jones DH, Morris JB, Morgan CP, Kondo H, Irvine RF, Cockcroft S (2000). 
Type I phosphatidylinositol 4-phosphate 5-kinase directly interacts with 
ADP-ribosylation factor 1 and is responsible for phosphatidylinositol 
4,5-bisphosphate synthesis in the Golgi compartment. J Biol Chem 275, 
13962–13966.
Jones S, Jedd G, Kahn RA, Franzusoff A, Bartolini F, Segev N (1999). 
Genetic interactions in yeast between Ypt GTPases and Arf guanine 
nucleotide exchangers. Genetics 152, 1543–1556.
Kahn RA, Bruford E, Inoue H, Logsdon JM, Nie ZZ, Premont RT, Randazzo 
PA, Satake M, Theibert AB, Zapp ML, et al. (2008). Consensus nomen-
clature for the human ArfGAP domain-containing proteins. J Cell Biol 
182, 1039–1044.
Kahn RA, Cherfils J, Elias M, Lovering RC, Munro S, Schurmann A (2006). 
Nomenclature for the human Arf family of GTP-binding proteins: ARF, 
ARL, and SAR proteins. J Cell Biol 172, 645–650.
Kam JL, Miura K, Jackson TR, Gruschus J, Roller P, Stauffer S, Clark J, Aneja 
R, Randazzo PA (2000). Phosphoinositide-dependent activation of the 
ADP-ribosylation factor GTPase-activating protein ASAP1. Evidence for 
1268 | E. Sztul et al. Molecular Biology of the Cell
the pleckstrin homology domain functioning as an allosteric site. J Biol 
Chem 275, 9653–9663.
Karandur D, Nawrotek A, Kuriyan J, Cherfils J (2017). Multiple interac-
tions between an Arf/GEF complex and charged lipids determine 
activation kinetics on the membrane. Proc Natl Acad Sci USA 114, 
11416–11421.
Khan AR, Menetrey J (2013). Structural biology of Arf and Rab GTPases’ 
effector recruitment and specificity. Structure 21, 1284–1297.
Khatter D, Sindhwani A, Sharma M (2015). Arf-like GTPase Arl8: moving 
from the periphery to the center of lysosomal biology. Cell Logist 5, 
e1086501.
Klinger CM, Spang A, Dacks JB, Ettema TJ (2016). Tracing the archaeal 
origins of eukaryotic membrane-trafficking system building blocks. Mol 
Biol Evol 33, 1528–1541.
Koronakis V, Hume PJ, Humphreys D, Liu T, Horning O, Jensen ON, McGhie 
EJ (2011). WAVE regulatory complex activation by cooperating GTPases 
Arf and Rac1. Proc Natl Acad Sci USA 108, 14449–14454.
Krugmann S, Anderson KE, Ridley SH, Risso N, McGregor A, Coadwell J, 
Davidson K, Eguinoa A, Ellson CD, Lipp P, et al. (2002). Identification 
of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, 
by selective capture on phosphoinositide affinity matrices. Mol Cell 9, 
95–108.
Lamorte L, Rodrigues S, Sangwan V, Turner CE, Park M (2003). Crk as-
sociates with a multimolecular Paxillin/GIT2/beta-PIX complex and 
promotes Rac-dependent relocalization of Paxillin to focal contacts. 
Mol Biol Cell 14, 2818–2831.
Lee SY, Yang JS, Hong WJ, Premont RT, Hsu VW (2005). ARFGAP1 plays 
a central role in coupling COPI cargo sorting with vesicle formation. 
J Cell Biol 168, 281–290.
Li CC, Chiang TC, Wu TS, Pacheco-Rodriguez G, Moss J, Lee FJ (2007). 
ARL4D recruits cytohesin-2/ARNO to modulate actin remodeling. Mol 
Biol Cell 18, 4420–4437.
Li HS, Shome K, Rojas R, Rizzo MA, Vasudevan C, Fluharty E, Santy LC, 
Casanova JE, Romero G (2003). The guanine nucleotide exchange 
factor ARNO mediates the activation of ARF and phospholipase D by 
insulin. BMC Cell Biol 4, 13.
Li J, Malaby AW, Famulok M, Sabe H, Lambright DG, Hsu VW (2012). Grp1 
plays a key role in linking insulin signaling to glut4 recycling. Dev Cell 
22, 1286–1298.
Li M, Tian L, Yao H, Lu J, Ge J, Guo Y, Liu M, Xiao H (2014). ASAP1 medi-
ates the invasive phenotype of human laryngeal squamous cell carci-
noma to affect survival prognosis. Oncol Rep 31, 2676–2682.
Li R, Peng C, Zhang X, Wu Y, Pan S, Xiao Y (2017). Roles of Arf6 in cancer 
cell invasion, metastasis and proliferation. Life Sci 182, 80–84.
Li Y, Kelly WG, Logsdon JM Jr, Schurko AM, Harfe BD, Hill-Harfe KL, Kahn 
RA (2004). Functional genomic analysis of the ADP-ribosylation factor 
family of GTPases: phylogeny among diverse eukaryotes and function in 
C. elegans. FASEB J 18, 1834–1850.
Li Y, Tian X, Ma M, Jerman S, Kong S, Somlo S, Sun Z (2016). Deletion of 
ADP ribosylation factor-like GTPase 13B leads to kidney cysts. J Am 
Soc Nephrol 27, 3628–3638.
Liew GM, Ye F, Nager AR, Murphy JP, Lee JS, Aguiar M, Breslow DK, Gygi 
SP, Nachury MV (2014). The intraflagellar transport protein IFT27 pro-
motes BBSome exit from cilia through the GTPase ARL6/BBS3. Dev Cell 
31, 265–278.
Lim J, Zhou M, Veenstra TD, Morrison DK (2010). The CNK1 scaffold binds 
cytohesins and promotes insulin pathway signaling. Genes Dev 24, 
1496–1506.
Lin JS, Jeon JS, Fan Q, Wong HN, Palmer MB, Holzman LB (2017). ARF6 
mediates nephrin tyrosine phosphorylation-induced podocyte cellular 
dynamics. PLoS One 12, e0184575.
Lin YC, Chiang TC, Liu YT, Tsai YT, Jang LT, Lee FJ (2011). ARL4A acts 
with GCC185 to modulate Golgi complex organization. J Cell Sci 124, 
4014–4026.
Liu X, Hu Y, Hao C, Rempel SA, Ye K (2007). PIKE-A is a proto-oncogene 
promoting cell growth, transformation and invasion. Oncogene 26, 
4918–4927.
Liu Y, Kahn RA, Prestegard JH (2009). Structure and membrane interaction 
of myristoylated ARF1. Structure 17, 79–87.
Liu Y, Kahn RA, Prestegard JH (2010). Dynamic structure of membrane-
anchored Arf*GTP. Nat Struct Mol Biol 17, 876–881.
Lock JG, Hammond LA, Houghton F, Gleeson PA, Stow JL (2005). E-cad-
herin transport from the trans-Golgi network in tubulovesicular carriers is 
selectively regulated by golgin-97. Traffic 6, 1142–1156.
Lowery J, Szul T, Styers M, Holloway Z, Oorschot V, Klumperman J, Sztul E 
(2013). The Sec7 guanine nucleotide exchange factor GBF1 regulates 
membrane recruitment of BIG1 and BIG2 to the trans-Golgi network 
(TGN). J Biol Chem 288, 11532–11545.
Lu J, Tiao G, Folkerth R, Hecht J, Walsh C, Sheen V (2006). Overlapping ex-
pression of ARFGEF2 and Filamin A in the neuroependymal lining of the 
lateral ventricles: insights into the cause of periventricular heterotopia. J 
Comp Neurol 494, 476–484.
Luo R, Chen PW, Kuo JC, Jenkins L, Jian X, Waterman CM, Randazzo PA 
(2018). ARAP2 inhibits Akt independently of its effects on focal adhe-
sions. Biol Cell 110, 257–270.
Luo R, Chen PW, Wagenbach M, Jian X, Jenkins L, Wordeman L, Randazzo 
PA (2016). Direct functional interaction of the kinesin-13 family member 
kinesin-like protein 2A (Kif2A) and Arf GAP with GTP-binding protein-
like, ankyrin repeats and PH domains 1 (AGAP1). J Biol Chem 291, 
25761.
Luo R, Ha VL, Hayashi R, Randazzo PA (2009). Arf GAP2 is positively regu-
lated by coatomer and cargo. Cell Signal 21, 1169–1179.
Luo R, Reed CE, Sload JA, Wordeman L, Randazzo PA, Chen PW (2017). Arf 
GAPs and molecular motors. Small GTPases 21, 1–14.
Luo RB, Randazzo PA (2008). Kinetic analysis of Arf GAP1 indicates a regula-
tory role for coatomer. J Biol Chem 283, 21965–21977.
Macia E, Chabre M, Franco M (2001). Specificities for the small G proteins 
ARF1 and ARF6 of the guanine nucleotide exchange factors ARNO and 
EFA6. J Biol Chem 276, 24925–24930.
Macia E, Luton F, Partisani M, Cherfils J, Chardin P, Franco M (2004). The 
GDP-bound form of Arf6 is located at the plasma membrane. J Cell Sci 
117, 2389–2398.
Malaby AW, van den Berg B, Lambright DG (2013). Structural basis for mem-
brane recruitment and allosteric activation of cytohesin family Arf GTPase 
exchange factors. Proc Natl Acad Sci USA 110, 14213–14218.
Manolea F, Chun J, Chen DW, Clarke I, Summerfeldt N, Dacks JB, Melan-
con P (2010). Arf3 is activated uniquely at the trans-Golgi network by 
brefeldin A-inhibited guanine nucleotide exchange factors. Mol Biol Cell 
21, 1836–1849.
Manolea F, Claude A, Chun J, Rosas J, Melancon P (2008). Distinct functions 
for Arf guanine nucleotide exchange factors at the Golgi complex: GBF1 
and BIGs are required for assembly and maintenance of the Golgi stack 
and trans-Golgi network, respectively. Mol Biol Cell 19, 523–535.
Matsumoto S, Fujii S, Sato A, Ibuka S, Kagawa Y, Ishii M, Kikuchi A (2014). A 
combination of Wnt and growth factor signaling induces Arl4c expres-
sion to form epithelial tubular structures. EMBO J 33, 702–718.
Matsuya S, Sakagami H, Tohgo A, Owada Y, Shin HW, Takeshima H, 
Nakayama K, Kokubun S, Kondo H (2005). Cellular and subcellular lo-
calization of EFA6C, a third member of the EFA6 family, in adult mouse 
Purkinje cells. J Neurochem 93, 674–685.
Mazaki Y, Nishimura Y, Sabe H (2012). GBF1 bears a novel phosphatidylino-
sitol-phosphate binding module, BP3K, to link PI3Kgamma activity with 
Arf1 activation involved in GPCR-mediated neutrophil chemotaxis and 
superoxide production. Mol Biol Cell 23, 2457–2467.
McDonold CM, Fromme JC (2014). Four GTPases differentially regulate the 
Sec7 Arf-GEF to direct traffic at the trans-Golgi network. Dev Cell 30, 
759–767.
Meissner JM, Bhatt JM, Lee E, Styers ML, Ivanova AA, Kahn RA, Sztul E 
(2018). The ARF guanine nucleotide exchange factor GBF1 is targeted 
to Golgi membranes through a PIP-binding domain. J Cell Sci 131, 
doi:10.1242/jcs.210245.
Mignot C, McMahon AC, Bar C, Campeau PM, Davidson C, Buratti J, Nava 
C, Jacquemont ML, Tallot M, Milh M, et al. (2018). IQSEC2-related 
encephalopathy in males and females: a comparative study including 37 
novel patients. Genet Med, doi:10.1038/s41436-018-0268-1.
Miura K, Jacques KM, Stauffer S, Kubosaki A, Zhu KJ, Hirsch DS, Resau J, 
Zheng Y, Randazzo PA (2002). ARAP1: a point of convergence for Arf 
and Rho signaling. Mol Cell 9, 109–119.
Miyamoto Y, Torii T, Tago K, Tanoue A, Takashima S, Yamauchi J (2018). 
BIG1/Arfgef1 and Arf1 regulate the initiation of myelination by Schwann 
cells in mice. Sci Adv 4, eaar4471.
Monetta P, Slavin I, Romero N, Alvarez C (2007). Rab1b interacts with GBF1, 
modulates both ARF1 dynamics and COPI association. Mol Biol Cell 18, 
2400–2410.
Moravec R, Conger KK, D’Souza R, Allison AB, Casanova JE (2012). BRAG2/
GEP100/IQSec1 interacts with clathrin and regulates α5β1 integrin 
endocytosis through activation of ADP ribosylation factor 5 (Arf5). J Biol 
Chem 287, 31138–31147.
Morishige M, Hashimoto S, Ogawa E, Toda Y, Kotani H, Hirose M, Wei S, 
Hashimoto A, Yamada A, Yano H, et al. (2008). GEP100 links epidermal 
growth factor receptor signalling to Arf6 activation to induce breast 
cancer invasion. Nat Cell Biol 10, 85–92.
Volume 30 May 15, 2019 ARF GTPases: concepts and challenges | 1269 
Mossessova E, Corpina RA, Goldberg J (2003). Crystal structure of 
ARF1*Sec7 complexed with Brefeldin A and its implications for the gua-
nine nucleotide exchange mechanism. Mol Cell 12, 1403–1411.
Mouratou B, Biou V, Joubert A, Cohen J, Shields DJ, Geldner N, Jurgens G, 
Melancon P, Cherfils J (2005). The domain architecture of large guanine 
nucleotide exchange factors for the small GTP-binding protein Arf. BMC 
Genomics 6, 20.
Mueller AG, Moser M, Kluge R, Leder S, Blum M, Buttner R, Joost HG, 
Schurmann A (2002). Embryonic lethality caused by apoptosis during 
gastrulation in mice lacking the gene of the ADP-ribosylation factor-
related protein 1. Mol Cell Biol 22, 1488–1494.
Muller T, Stein U, Poletti A, Garzia L, Rothley M, Plaumann D, Thiele W, 
Bauer M, Galasso A, Schlag P, et al. (2010). ASAP1 promotes tumor cell 
motility and invasiveness, stimulates metastasis formation in vivo, and 
correlates with poor survival in colorectal cancer patients. Oncogene 29, 
2393–2403.
Munro S (2005). The Arf-like GTPase Arl1 and its role in membrane traffic. 
Biochem Soc Trans 33(Pt 4), 601–605.
Murray RZ, Stow JL (2014). Cytokine secretion in macrophages: SNAREs, 
Rabs, and membrane trafficking. Front Immunol 5, 538.
Nakayama K (2016). Regulation of cytokinesis by membrane trafficking 
involving small GTPases and the ESCRT machinery. Crit Rev Biochem 
Mol Biol 51, 1–6.
Natsume W, Tanabe K, Kon S, Yoshida N, Watanabe T, Torii T, Satake 
M (2006). SMAP2, a novel ARF GTPase-activating protein, interacts 
with clathrin and clathrin assembly protein and functions on the 
AP-1-positive early endosome/trans-Golgi network. Mol Biol Cell 17, 
2592–2603.
Newman LE, Schiavon CR, Turn RE, Kahn RA (2017). The ARL2 GTPase 
regulates mitochondrial fusion from the intermembrane space. Cell 
Logist 7, e1340104.
Newman LE, Zhou CJ, Mudigonda S, Mattheyses AL, Paradies E, Marobbio 
CM, Kahn RA (2014). The ARL2 GTPase is required for mitochondrial 
morphology, motility, and maintenance of ATP levels. PLoS One 9, 
e99270.
Nie ZZ, Stanley KT, Stauffer S, Jacques KM, Hirsch DS, Takei J, Randazzo PA 
(2002). AGAP1, an endosome-associated, phosphoinositide-dependent 
ADP-ribosylation factor GTPase-activating protein that affects actin 
cytoskeleton. J Biol Chem 277, 48965–48975.
Nishimoto-Morita K, Shin HW, Mitsuhashi H, Kitamura M, Zhang Q, 
Johannes L, Nakayama K (2009). Differential effects of depletion of ARL1 
and ARFRP1 on membrane trafficking between the trans-Golgi network 
and endosomes. J Biol Chem 284, 10583–10592.
Nishiya N, Kiosses WB, Han JW, Ginsberg MH (2005). An alpha(4) integrin-
paxillin-Arf-GAP complex restricts Rac activation to the leading edge of 
migrating cells. Nat Cell Biol 7, U343–U347.
Oh SJ, Santy LC (2010). Differential effects of cytohesins 2 and 3 on beta1 
integrin recycling. J Biol Chem 285, 14610–14616.
Oh SJ, Santy LC (2012). Phosphoinositide specificity determines which 
cytohesins regulate beta1 integrin recycling. J Cell Sci 125(Pt 13), 
3195–3201.
Onodera Y, Hashimoto S, Hashimoto A, Morishige M, Mazaki Y, Yamada 
A, Ogawa E, Adachi M, Sakurai T, Manabe T, et al. (2005). Expression 
of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer 
invasive activities. EMBO J 24, 963–973.
Ooi CE, Dell’Angelica EC, Bonifacino JS (1998). ADP-Ribosylation factor 1 
(ARF1) regulates recruitment of the AP-3 adaptor complex to mem-
branes. J Cell Biol 142(2), 391–402.
Pacheco-Rodriguez G, Moss J, Vaughan M (2002). BIG1 and BIG2: brefeldin 
A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation 
factors. Methods Enzymol 345, 397–404.
Padilla PI, Pacheco-Rodriguez G, Moss J, Vaughan M (2004). Nuclear local-
ization and molecular partners of BIG1, a brefeldin A-inhibited guanine 
nucleotide-exchange protein for ADP-ribosylation factors. Proc Natl 
Acad Sci USA 101, 2752–2757.
Padilla PI, Uhart M, Pacheco-Rodriguez G, Peculis BA, Moss J, Vaughan M 
(2008). Association of guanine nucleotide-exchange protein BIG1 in 
HepG2 cell nuclei with nucleolin, U3 snoRNA, and fibrillarin. Proc Natl 
Acad Sci USA 105, 3357–3361.
Padovani D, Folly-Klan M, Labarde A, Boulakirba S, Campanacci V, Franco 
M, Zeghouf M, Cherfils J (2014). EFA6 controls Arf1 and Arf6 activa-
tion through a negative feedback loop. Proc Natl Acad Sci USA 111, 
12378–12383.
Pan T, Sun J, Zhou J, Fu Z, Hu Y, Zheng S, Zhang S (2013). Function and 
mode of action of cytohesins in the epidermal growth factor pathway in 
colorectal cancer cells. Oncol Lett 5, 521–526.
Panic B, Whyte JR, Munro S (2003). The ARF-like GTPases Arl1p and Arl3p 
act in a pathway that interacts with vesicle-tethering factors at the Golgi 
apparatus. Curr Biol 13, 405–410.
Pasqualato S, Renault L, Cherfils J (2002). Arf, Arl, Arp and Sar proteins: a 
family of GTP-binding proteins with a structural device for “front-back” 
communication. EMBO Rep 3, 1035–1041.
Patel M, Chiang T-C, Tran V, Lee F-JS, Côté J-F (2011). The Arf family 
GTPase Arl4A complexes with ELMO proteins to promote actin cyto-
skeleton remodeling and reveals a versatile Ras-binding domain in the 
ELMO proteins family. J Biol Chem 286, 38969–38979.
Pearring JN, San Agustin JT, Lobanova ES, Gabriel CJ, Lieu EC, Monis WJ, 
Stuck MW, Strittmatter L, Jaber SM, Arshavsky VY, et al. (2017). Loss of 
Arf4 causes severe degeneration of the exocrine pancreas but not cystic 
kidney disease or retinal degeneration. PLoS Genet 13, e1006740.
Peurois F, Veyron S, Ferrandez Y, Ladid I, Benabdi S, Zeghouf M, Peyroche 
G, Cherfils J (2017). Characterization of the activation of small GTPases 
by their GEFs on membranes using artificial membrane tethering. 
Biochem J 474, 1259–1272.
Peyroche A, Antonny B, Robineau S, Acker J, Cherfils J, Jackson CL (1999). 
Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein 
complex: involvement of specific residues of the Sec7 domain. Mol Cell 
3, 275–285.
Peyroche A, Paris S, Jackson CL (1996). Nucleotide exchange on ARF medi-
ated by yeast Gea1 protein. Nature 384, 479–481.
Pocognoni CA, Viktorova EG, Wright J, Meissner JM, Sager G, Lee E, Belov 
GA, Sztul E (2018). Highly conserved motifs within the large Sec7 ARF 
guanine nucleotide exchange factor GBF1 target it to the Golgi and are 
critical for GBF1 activity. Am J Physiol Cell Physiol 314, C675–C689.
Porter AP, Papaioannou A, Malliri A (2016). Deregulation of Rho GTPases in 
cancer. Small GTPases 7, 123–138.
Qi Q, Kang SS, Zhang S, Pham C, Fu H, Brat DJ, Ye K (2017). Co-amplifi-
cation of phosphoinositide 3-kinase enhancer A and cyclin-dependent 
kinase 4 triggers glioblastoma progression. Oncogene 36, 4562–4572.
Randazzo PA, Andrade J, Miura K, Brown MT, Long YQ, Stauffer S, Roller P, 
Cooper JA (2000). The Arf GTPase-activating protein ASAP1 regulates 
the actin cytoskeleton. Proc Natl Acad Sci USA 97, 4011–4016.
Randazzo PA, Hirsch DS (2004). Arf GAPs: multifunctional proteins that regu-
late membrane traffic and actin remodelling. Cell Signal 16, 401–413.
Randazzo PA, Inoue H, Bharti S (2007). Arf GAPs as regulators of the actin 
cytoskeleton. Biol Cell 99, 583–600.
Ratcliffe CDH, Siddiqui N, Coelho PP, Laterreur N, Cookey TN, Sonenberg 
N, Park M (2018). HGF-induced migration depends on the PI(3,4,5)
P3-binding microexon-spliced variant of the Arf6 exchange factor 
cytohesin-1. J Cell Biol, doi:10.1083/jcb.201804106.
Ren X, Farias GG, Canagarajah BJ, Bonifacino JS, Hurley JH (2013). Struc-
tural basis for recruitment and activation of the AP-1 clathrin adaptor 
complex by Arf1. Cell 152, 755–767.
Renault L, Guibert B, Cherfils J (2003). Structural snapshots of the mecha-
nism and inhibition of a guanine nucleotide exchange factor. Nature 
426, 525–530.
Reviriego-Mendoza MM, Santy LC (2015). The cytohesin guanosine 
exchange factors (GEFs) are required to promote HGF-mediated renal 
recovery after acute kidney injury (AKI) in mice. Physiol Rep 3, e12442.
Rodiger M, Werno MW, Wilhelmi I, Baumeier C, Hesse D, Wettschureck 
N, Offermanns S, Song K, Krauss M, Schurmann A (2018). Adiponectin 
release and insulin receptor targeting share trans-Golgi-dependent 
endosomal trafficking routes. Mol Metab 8, 167–179.
Rosa-Ferreira C, Christis C, Torres IL, Munro S (2015). The small G protein 
Arl5 contributes to endosome-to-Golgi traffic by aiding the recruitment 
of the GARP complex to the Golgi. Biol Open 4, 474–481.
Roy NS, Yohe ME, Randazzo PA, Gruschus JM (2016). Allosteric properties 
of PH domains in Arf regulatory proteins. Cell Logist 6, e1181700.
Sakagami H, Suzuki H, Kamata A, Owada Y, Fukunaga K, Mayanagi H, 
Kondo H (2006). Distinct spatiotemporal expression of EFA6D, a gua-
nine nucleotide exchange factor for ARF6, among the EFA6 family in 
mouse brain. Brain Res 1093, 1–11.
Sakurai A, Jian X, Lee CJ, Manavski Y, Chavakis E, Donaldson J, Randazzo 
PA, Gutkind JS (2011). Phosphatidylinositol-4-phosphate 5-kinase and 
GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 
3E-plexin-D1 through Arf6 protein. J Biol Chem 286, 34335–34345.
Salem JC, Reviriego-Mendoza MM, Santy LC (2015). ARF-GEF cytohesin-2/
ARNO regulates R-Ras and α5-integrin recycling through an EHD1-
positive compartment. Mol Biol Cell 26, 4265–4279.
Santy LC, Casanova JE (2001). Activation of ARF6 by ARNO stimulates epi-
thelial cell migration through downstream activation of both Rac1 and 
phospholipase D. J Cell Biol 154, 599–610.
1270 | E. Sztul et al. Molecular Biology of the Cell
Santy LC, Ravichandran KS, Casanova JE (2005). The DOCK180/Elmo 
complex couples ARNO-mediated Arf6 activation to the downstream 
activation of Rac1. Curr Biol 15, 1749–1754.
Scheffzek K, Ahmadian MR, Wittinghofer A (1998). GTPase-activating 
proteins: helping hands to complement an active site. Trends Biochem 
Sci 23, 257–262.
Schiavon CR, Griffin ME, Pirozzi M, Parashuraman R, Zhou W, Jinnah HA, 
Reines D, Kahn RA (2018). Compositional complexity of rods and rings. 
Mol Biol Cell 29, 2303–2316.
Schlacht A, Mowbrey K, Elias M, Kahn RA, Dacks JB (2013). Ancient com-
plexity, opisthokont plasticity, and discovery of the 11th subfamily of Arf 
GAP proteins. Traffic 14, 636–649.
Scholz R, Berberich S, Rathgeber L, Kolleker A, Kohr G, Kornau HC (2010). 
AMPA receptor signaling through BRAG2 and Arf6 critical for long-term 
synaptic depression. Neuron 66, 768–780.
Schrick JJ, Vogel P, Abuin A, Hampton B, Rice DS (2006). ADP-ribosylation 
factor-like 3 is involved in kidney and photoreceptor development. Am J 
Pathol 168, 1288–1298.
Schurmann A, Koling S, Jacobs S, Saftig P, Krauss S, Wennemuth G, Kluge 
R, Joost HG (2002). Reduced sperm count and normal fertility in male 
mice with targeted disruption of the ADP-ribosylation factor-like 4 (Arl4) 
gene. Mol Cell Biol 22, 2761–2768.
Schweitzer JK, Sedgwick AE, D’Souza-Schorey C (2011). ARF6-mediated 
endocytic recycling impacts cell movement, cell division and lipid ho-
meostasis. Semin Cell Dev Biol 22, 39–47.
Seixas E, Barros M, Seabra MC, Barral DC (2013). Rab and Arf proteins in 
genetic diseases. Traffic 14, 871–885.
Serafini T, Orci L, Amherdt M, Brunner M, Kahn RA, Rothman JE (1991). ADP-
ribosylation factor is a subunit of the coat of Golgi-derived COP-coated 
vesicles: a novel role for a GTP-binding protein. Cell 67, 239–253.
Setty SR, Shin ME, Yoshino A, Marks MS, Burd CG (2003). Golgi recruitment 
of GRIP domain proteins by Arf-like GTPase 1 is regulated by Arf-like 
GTPase 3. Curr Biol 13, 401–404.
Sharer JD, Kahn RA (1999). The ARF-like 2 (ARL2)-binding protein, BART. 
Purification, cloning, and initial characterization. J Biol Chem 274, 
27553–27561.
Sheen VL, Ganesh VS, Topcu M, Sebire G, Bodell A, Hill RS, Grant PE, 
Shugart YY, Imitola J, Khoury SJ, et al. (2004). Mutations in ARFGEF2 
implicate vesicle trafficking in neural progenitor proliferation and migra-
tion in the human cerebral cortex. Nat Genet 36, 69–76.
Shiba Y, Luo R, Hinshaw JE, Szul T, Hayashi R, Sztul E, Nagashima K, Baxa 
U, Randazzo PA (2011). ArfGAP1 promotes COPI vesicle formation by 
facilitating coatomer polymerization. Cell Logist 1, 139–154.
Shiba Y, Randazzo PA (2012). ArfGAP1 function in COPI mediated mem-
brane traffic: currently debated models and comparison to other coat-
binding ArfGAPs. Histol Histopathol 27, 1143–1153.
Shin HW, Kobayashi H, Kitamura M, Waguri S, Suganuma T, Uchiyama Y, 
Nakayama K (2005). Roles of ARFRP1 (ADP-ribosylation factor-related 
protein 1) in post-Golgi membrane trafficking. J Cell Sci 118(Pt 17), 
4039–4048.
Shinotsuka C, Waguri S, Wakasugi M, Uchiyama Y, Nakayama K (2002a). 
Dominant-negative mutant of BIG2, an ARF-guanine nucleotide 
exchange factor, specifically affects membrane trafficking from the trans-
Golgi network through inhibiting membrane association of AP-1 and 
GGA coat proteins. Biochem Biophys Res Commun 294, 254–260.
Shinotsuka C, Yoshida Y, Kawamoto K, Takatsu H, Nakayama K (2002b). 
Overexpression of an ADP-ribosylation factor-guanine nucleotide 
exchange factor, BIG2, uncouples brefeldin A-induced adaptor pro-
tein-1 coat dissociation and membrane tubulation. J Biol Chem 277, 
9468–9473.
Spang A, Saw JH, Jorgensen SL, Zaremba-Niedzwiedzka K, Martijn J, Lind 
AE, van Eijk R, Schleper C, Guy L, Ettema TJ (2015). Complex archaea 
that bridge the gap between prokaryotes and eukaryotes. Nature 521, 
173–179.
Spang A, Shiba Y, Randazzo PA (2010). Arf GAPs: gatekeepers of vesicle 
generation. FEBS Lett 584, 2646–2651.
Sparrer KMJ, Gableske S, Zurenski MA, Parker ZM, Full F, Baumgart GJ, 
Kato J, Pacheco-Rodriguez G, Liang C, Pornillos O, et al. (2017). TRIM23 
mediates virus-induced autophagy via activation of TBK1. Nat Microbiol 
2, 1543–1557.
Stacey TTI, Nie ZZ, Stewart A, Najdovska M, Hall NE, He H, Randazzo PA, 
Lock P (2004). ARAP3 is transiently tyrosine phosphorylated in cells 
attaching to fibronectin and inhibits cell spreading in a RhoGAP-depen-
dent manner. J Cell Sci 117, 6071–6084.
Stalder D, Antonny B (2013). Arf GTPase regulation through cascade 
mechanisms and positive feedback loops. FEBS Lett 587, 2028–2035.
Stamnes MA, Rothman JE (1993). The binding of AP-1 clathrin adaptor 
particles to Golgi membranes requires ADP-ribosylation factor, a small 
GTP-binding protein. Cell 73, 999–1005.
Suckling RJ, Poon PP, Travis SM, Majoul IV, Hughson FM, Evans PR, Duden 
R, Owen DJ (2015). Structural basis for the binding of tryptophan-based 
motifs by delta-COP. Proc Natl Acad Sci USA 112, 14242–14247.
Suzuki T, Kanai Y, Hara T, Sasaki J, Sasaki T, Kohara M, Maehama T, Taya C, 
Shitara H, Yonekawa H, et al. (2006). Crucial role of the small GTPase 
ARF6 in hepatic cord formation during liver development. Mol Cell Biol 
26, 6149–6156.
Szul T, Grabski R, Lyons S, Morohashi Y, Shestopal S, Lowe M, Sztul E (2007). 
Dissecting the role of the ARF guanine nucleotide exchange factor GBF1 in 
Golgi biogenesis and protein trafficking. J Cell Sci 120(Pt 22), 3929–3940.
Takashima K, Saitoh A, Hirose S, Nakai W, Kondo Y, Takasu Y, Kakeya H, 
Shin HW, Nakayama K (2011). GBF1-Arf-COPI-ArfGAP-mediated Golgi-
to-ER transport involved in regulation of lipid homeostasis. Cell Struct 
Funct 36, 223–235.
Tanabe K, Torii T, Natsume W, Braesch-Andersen S, Watanabe T, Satake M 
(2005). A novel GTPase-activating protein for ARF6 directly interacts 
with clathrin and regulates clathrin-dependent endocytosis. Mol Biol 
Cell 16, 1617–1628.
Torii T, Miyamoto Y, Sanbe A, Nishimura K, Yamauchi J, Tanoue A (2010). 
Cytohesin-2/ARNO, through its interaction with focal adhesion adaptor 
protein paxillin, regulates preadipocyte migration via the downstream 
activation of Arf6. J Biol Chem 285, 24270–24281.
Traub LM, Ostrom JA, Kornfeld S (1993). Biochemical dissection of AP-1 
recruitment onto Golgi membranes. J Cell Biol 123, 561–573.
Turner CE, West KA, Brown MC (2001). Paxillin-ARF GAP signaling and the 
cytoskeleton. Curr Opin Cell Biol 13, 593–599.
Van Valkenburgh H, Shern JF, Sharer JD, Zhu X, Kahn RA (2001). ADP-
ribosylation factors (ARFs) and ARF-like 1 (ARL1) have both specific and 
shared effectors: characterizing ARL1-binding proteins. J Biol Chem 276, 
22826–22837.
Venkateswarlu K, Gunn-Moore F, Oatey PB, Tavare JM, Cullen PJ (1998a). 
Nerve growth factor- and epidermal growth factor-stimulated trans-
location of the ADP-ribosylation factor-exchange factor GRP1 to the 
plasma membrane of PC12 cells requires activation of phosphatidylino-
sitol 3-kinase and the GRP1 pleckstrin homology domain. Biochem J 
335(Pt 1), 139–146.
Venkateswarlu K, Oatey PB, Tavare JM, Cullen PJ (1998b). Insulin-depen-
dent translocation of ARNO to the plasma membrane of adipocytes 
requires phosphatidylinositol 3-kinase. Curr Biol 8, 463–466.
Vichi A, Moss J, Vaughan M (2005). ADP-ribosylation factor domain protein 
1 (ARD1), a multifunctional protein with ubiquitin E3 ligase, GAP, and 
ARF domains. Methods Enzymol 404, 195–206.
Vitali T, Girald-Berlingeri S, Randazzo PA, Chen PW (2017). Arf GAPs: a 
family of proteins with disparate functions that converge on a com-
mon structure, the integrin adhesion complex. Small GTPases, 
doi:10.1080/21541248.2017.1299271.
Volpicelli-Daley LA, Li Y, Zhang CJ, Kahn RA (2005). Isoform-selective effects 
of the depletion of ADP-ribosylation factors 1–5 on membrane traffic. 
Mol Biol Cell 16, 4495–4508.
Watanabe M, Takahashi H, Saeki Y, Ozaki T, Itoh S, Suzuki M, Mizushima 
W, Tanaka K, Hatakeyama S (2015). The E3 ubiquitin ligase TRIM23 
regulates adipocyte differentiation via stabilization of the adipogenic 
activator PPARgamma. Elife 4, e05615.
Weimer C, Beck R, Eckert P, Reckmann I, Moelleken J, Brugger B, Wieland 
F (2008). Differential roles of ArfGAP1, ArfGAP2, and ArfGAP3 in COPI 
trafficking. J Cell Biol 183, 725–735.
West MA, Bright NA, Robinson MS (1997). The role of ADP-ribosylation 
factor and phospholipase D in adaptor recruitment. J Cell Biol 138, 
1239–1254.
White DT, McShea KM, Attar MA, Santy LC (2010). GRASP and IPCEF pro-
mote ARF-to-Rac signaling and cell migration by coordinating the asso-
ciation of ARNO/cytohesin 2 with Dock180. Mol Biol Cell 21, 562–571.
Wiens CJ, Tong Y, Esmail MA, Oh E, Gerdes JM, Wang J, Tempel W, Rattner 
JB, Katsanis N, Park HW, et al. (2010). Bardet-Biedl syndrome-associated 
small GTPase ARL6 (BBS3) functions at or near the ciliary gate and 
modulates Wnt signaling. J Biol Chem 285, 16218–16230.
Wright J, Kahn RA, Sztul E (2014). Regulating the large Sec7 ARF guanine 
nucleotide exchange factors: the when, where and how of activation. 
Cell Mol Life Sci 71, 3419–3438.
Wright ZC, Loskutov Y, Murphy D, Stoilov P, Pugacheva E, Goldberg AFX, 
Ramamurthy V (2018). ADP-ribosylation factor-like 2 (ARL2) regulates 
cilia stability and development of outer segments in rod photoreceptor 
neurons. Sci Rep 8, 16967.
Volume 30 May 15, 2019 ARF GTPases: concepts and challenges | 1271 
Yang JS, Lee SY, Gao MG, Bourgoin S, Randazzo PA, Premont RT, 
Hsu VW (2002). ARFGAP1 promotes the formation of COPI vesicles, 
suggesting function as a component of the coat. J Cell Biol 159, 
69–78.
Yano H, Kobayashi I, Onodera Y, Luton F, Franco M, Mazaki Y, Hashimoto S, 
Iwai K, Ronai Z, Sabe H (2008). Fbx8 makes Arf6 refractory to function 
via ubiquitination. Mol Biol Cell 19, 822–832.
Ye F, Nager AR, Nachury MV (2018). BBSome trains remove activated 
GPCRs from cilia by enabling passage through the transition zone. 
J Cell Biol 217, 1847–1868.
Yendamuri S, Trapasso F, Calin GA (2008). ARLTS1—a novel tumor 
suppressor gene. Cancer Lett 264, 11–20.
Yin GY, Zheng QL, Yan C, Berk BC (2005). GIT1 is a scaffold for ERK1/2 
activation in focal adhesions. J Biol Chem 280, 27705–27712.
Yoo JH, Shi DS, Grossmann AH, Sorensen LK, Tong Z, Mleynek TM, Rogers 
A, Zhu W, Richards JR, Winter JM, et al. (2016). ARF6 is an actionable 
node that orchestrates oncogenic GNAQ signaling in uveal melanoma. 
Cancer Cell 29, 889–904.
Yoon HY, Lee JS, Randazzo PA (2008). ARAP1 regulates endocytosis of 
EGFR. Traffic 9, 2236–2252.
Yoon HY, Miura K, Cuthbert EJ, Davis KK, Ahvazi B, Casanova JE, Randazzo 
PA (2006). ARAP2 effects on the actin cytoskeleton are dependent on 
Arf6-specific GTPase-activating-protein activity and binding to RhoA-
GTP. J Cell Sci 119, 4650–4666.
Yu C-J, Lee F-JS (2017). Multiple activities of Arl1 GTPase in the trans-Golgi 
network. J Cell Sci 130, 1691–1699.
Yu X, Breitman M, Goldberg J (2012). A structure-based mechanism for 
Arf1-dependent recruitment of coatomer to membranes. Cell 148, 
530–542.
Zahn C, Hommel A, Lu L, Hong W, Walther DJ, Florian S, Joost HG, 
Schurmann A (2006). Knockout of Arfrp1 leads to disruption of ARF-
like1 (ARL1) targeting to the trans-Golgi in mouse embryos and HeLa 
cells. Mol Membr Biol 23, 475–485.
Zahn C, Jaschke A, Weiske J, Hommel A, Hesse D, Augustin R, Lu L, Hong 
W, Florian S, Scheepers A, et al. (2008). ADP-ribosylation factor-like 
GTPase ARFRP1 is required for trans-Golgi to plasma membrane traf-
ficking of E-cadherin. J Biol Chem 283, 27179–27188.
Zaremba-Niedzwiedzka K, Caceres EF, Saw JH, Backstrom D, Juzokaite L, 
Vancaester E, Seitz KW, Anantharaman K, Starnawski P, Kjeldsen KU, 
et al. (2017). Asgard archaea illuminate the origin of eukaryotic cellular 
complexity. Nature 541, 353–358.
Zhang CJ, Cavenagh MM, Kahn RA (1998). A family of Arf effectors defined 
as suppressors of the loss of Arf function in the yeast Saccharomyces-
cerevisiae. J Biol Chem 273, 19792–19796.
Zhang CJ, Rosenwald AG, Willingham MC, Skuntz S, Clark J, Kahn 
RA (1994). Expression of a dominant allele of human ARF1 inhibits 
membrane traffic in vivo. J Cell Biol 124, 289–300.
Zhang Q, Hu J, Ling K (2013). Molecular views of Arf-like small GTPases in 
cilia and ciliopathies. Exp Cell Res 319, 2316–2322.
Zhang Q, Nishimura D, Seo S, Vogel T, Morgan DA, Searby C, Bugge K, 
Stone EM, Rahmouni K, Sheffield VC (2011). Bardet-Biedl syndrome 
3 (Bbs3) knockout mouse model reveals common BBS-associated 
phenotypes and Bbs3 unique phenotypes. Proc Natl Acad Sci USA 
108, 20678–20683.
Zhao X, Claude A, Chun J, Shields DJ, Presley JF, Melancon P (2006). GBF1, 
a cis-Golgi and VTCs-localized ARF-GEF, is implicated in ER-to-Golgi 
protein traffic. J Cell Sci 119(Pt 18), 3743–3753.
Zhao X, Lasell TK, Melancon P (2002). Localization of large ADP-ribosylation 
factor-guanine nucleotide exchange factors to different Golgi compart-
ments: evidence for distinct functions in protein traffic. Mol Biol Cell 13, 
119–133.
Zhao ZS, Manser E, Loo TH, Lim L (2000). Coupling of PAK-interacting 
exchange factor PIX to GIT1 promotes focal complex disassembly. 
Mol Cell Biol 20, 6354–6363.
Zhou C, Cunningham L, Marcus AI, Li Y, Kahn RA (2006). Arl2 and Arl3 
regulate different microtubule-dependent processes. Mol Biol Cell 
17, 2476–2487.
Zhou W, Li XB, Premont RT (2016). Expanding functions of GIT Arf GTPase-
activating proteins, PIX Rho guanine nucleotide exchange factors and 
GIT-PIX complexes. J Cell Sci 129, 1963–1974.
